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Abstract 
Small interfering RNA (siRNA), when delivered to cells, is able to elicit a potent post 
transcriptional gene silencing with enormous therapeutic potential. It has been demonstrated that 
siRNA is able to tackle a wide range of conditions that include viral infections, cancer, 
immunological disorders, and even alcoholism. Still, siRNA is too large to passively internalize 
into the cells by means of diffusion, and its electric charge is of the same polarity as the net-anionic 
plasma membranes, making it difficult to even approach the cells. As such, various materials have 
been developed to allow the delivery of the siRNA molecules to their primary sites of activity in 
cytosol. This, however, only solved the problem in part, since such vectors interact with 
oligonucleotides to form particles that, as commonly believed, require endocytosis to enter the 
cells.  
Endocytosis is a process by which cells communicate with their surroundings and 
internalize nutrients. The fundamental principle in this process is that the internalized material is 
secluded from the cytosol in vesicles formed by invaginations of sections of plasma membranes. 
These vesicles transport and sort material in a highly organized manner and most commonly either 
recycle the internalized material out of the cells or deliver it to be degraded in lysosomes. Once 
again, in order to enter cytosol, siRNA molecules must cross a biological membrane. Thousands 
of chemical formulations have been adapted or de novo synthesized to overcome the various 
barriers to siRNA delivery. These include targeting to specific cells, evasion from immune system, 
cell internalization, and escape from the endocytic vesicles into cytosol. Still, it is has been a great 
challenge to design a vector material capable of mediating the delivery of siRNA into the cytosol.  
The research presented in this dissertation will illuminate the reasons behind the success 
of some of the most common delivery materials: polyethylenimine (PEI) and N-[1-(2,3-
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dioleoyloxy)propyl]-N,N,N-trimethylammonium methyl-sulfate (DOTAP) liposomes with 
various amounts of cholesterol as “helper lipids.” Multiple techniques were used in an attempt to 
gain new insights into the endocytosis of siRNA-based synthetic particles. These included confocal 
microscopy, sedimentation and buoyancy-based subcellular fractionations. However, these did not 
provide for sufficient resolution required to quantify the movement of the particles between the 
major stations within the endolysosomal system. Therefore, I exploited the ability of horseradish 
peroxidase (HRP) to elicit crosslinking and subsequent isolation of different groups of vesicles 
within the endocytic system. This method allows for a quantitative description of the intracellular 
kinetics of internalized complexes, and was demonstrated to be superior to other commonly used 
methods.  
The data acquired by this method were used to construct a mathematical model describing 
endocytosis of the investigated vectors that revealed a series of interesting results; the success of 
PEI is based on the ability of the PEI-based particles to attach to plasma membranes. PEI-based 
particles internalize into early endosomes and gain access to cytosol primarily from early 
endosomes 14 minutes after the internalization. On the contrary, DOTAP/cholesterol liposomes 
primarily gain access to cytosol through direct fusion with plasma membranes, and increasing the 
content of cholesterol in the vectors was shown to enhance the fusion of the lipid-based particles 
with the biological membranes. However, once the liposomes enter the cells, their ability to escape 
the internal vesicles is not a substantial contributor to their success. The methods and the kinetics 
parameters presented in this dissertation will aid in rational development of siRNA vectors and 
provide means by which the intracellular trafficking of the internalized particles can be 
investigated.       
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Chapter 1. Background 
1.1 Introduction 
siRNA-induced gene silencing can be achieved by as few as 10 exogenously delivered siRNA 
molecules1, and  only 12 molecules delivered to cytosol by microinjection resulted in 50% of the 
maximum achievable inhibition of the targeted protein expression2. However, to accomplish this 
task the genetic material has to overcome several extracellular and intracellular barriers3.  
Unmodified and free siRNA molecules are rarely capable of successfully overcoming the hurdles 
of their journey into the cytosol, the main site of their action. Hence, a carrier is required to assist 
in the siRNA delivery. Because of the anionic nature of siRNA, it can readily form particles when 
combined with cationic materials. Despite substantial investments into the research and 
development of siRNA-based medicines, very few clinical trials have demonstrated promising 
results4–6. This appears to be a consequence of the lack of a rational design approach that is rarely 
undertaken in the design of vectors7. Most commonly, investigators try to include desired chemical 
properties in the designed vectors based on reasonable assumptions that the modification will help 
to overcome the limiting delivery barrier8. But this approach is not easy to implement since the 
biological mechanisms of these barriers are not clear.  
1.2 Delivery barriers and endocytosis 
When a therapeutic is delivered by intravenous injection, it should first survive the rheological 
stress in blood vessels, evade the immune system and other clearance mechanisms (i.e., renal 
filtration, hepatic metabolism, reticuloendothelial system), attach to the target cells, be internalized 
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by these cells and reach the appropriate intracellular location where the therapeutic can achieve 
the desired effect.  
Endocytosis is primarily responsible for cellular internalization of these molecules9. This 
complex process consists of several pathways that can be distinguished based on their protein 
machinery (receptors, adapter proteins, lipoproteins)10–12. All pathways feature invagination of a 
section of plasma membranes (PMs) that forms primary endocytic vesicles. These typically fuse 
with early endosomes (EEs) shortly after the internalization10,13,14. The majority of the endocytosed 
membrane components recycle back to the cell surface with some continuing toward the lysosomes 
(LYs)13. One of the classical interpretations of EE is that it is a tubular-vesicular structure with a 
mosaic of domains with various regulation mechanisms. As the vesicles mature, their intraluminal 
pH drops, and this leads to a dissociation of endocytosed complexes to membrane-bound receptors 
and ligands. The tubular structures in EEs have high surface-area-to-volume ratio compared to the 
vesicular sections, so most of the free ligands and soluble molecules remain in the vesicular section 
of EEs while the receptors localize to the tubular sections. The small-diameter tubules pinch off 
from the EEs and carry the receptors either back to PM or to recycling endosomes. This geometry-
based sorting process is highly efficient, as it iteratively segregates soluble from membrane-bound 
material.  
Shortly after the internalization event (often/typically within 10 min), the EEs stop accepting 
incoming cargo and their vesicular sections detach from the main body and form late endosomes 
(LEs). Even before this process happens, EEs begin forming intraluminal vesicles from the 
invagination of their membranes inward. Hence, by the time that the LEs are formed, they contain 
50 – 100 nm internal vesicles that continue to increase in numbers up to a few dozen. Like the 
majority of vesicles in the endosomal system, LEs are multifunctional. They can carry enzymes 
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from Golgi to LYs, and they can form exosomes by releasing their intraluminal vesicles after 
moving back to PM13,15.  
This common interpretation of the sorting and maturation process is crude, since it does not 
emphasize the heterogeneity of the vesicles, the formation of hybrid intermediates, the recycling 
to PM that was observed from most of the endosomal compartments and the material exchange 
between these compartments and trans-Golgi network or between each other bypassing some of 
the intermediate steps 13,14,16. Therefore, a number of alternative descriptions of sorting and 
exchange of receptors and cargos between the compartments and the origin of the compartments 
exists14,17,18. It is important to emphasize that it is not only quantitative data on the endocytosis 
steps that is lacking, but also many of the mechanisms and the principles by which the intracellular 
trafficking occurs are not known. There exists, therefore, a challenge and an opportunity to study 
the kinetics of nanoparticle uptake and processing from a quantitative perspective as opposed to 
one that is concentrated on yet poorly understood mechanistic outlook. There is also a need to 
develop new tools and approaches to better characterize the performance of the delivery vectors. 
1.3 Vectors 
To help overcome the extracellular and intracellular barriers (including sorting and recycling 
steps) to effective nucleic acid delivery, anionic siRNA and DNA molecules are often complexed 
with cationic lipids or polymers to form particles3,9,19. These particles must protect the nucleic 
acids while delivering them to specific intracellular locations and subsequently disassemble, 
releasing the payload at these locations. These criteria can be called “dilemmatic20,” and imply 
that the designed vector materials will have to strongly bind to the DNA or siRNA at the initial 
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stages of delivery but then react to the highly dynamic intracellular environment in order to be 
effective at releasing the cargo. Thus, it is imperative to know the optimal location of the delivery. 
The cationic polymers for nucleic acids delivery applications traditionally contain protonable 
amines. Various linkers and functional groups that activate in weakly reducing conditions of 
cytosol or acidity of endosomes are commonly used with various success to promote gene delivery 
efficiency3,20,21. The success of many of the cationic polymers is usually attributed to their ability 
to buffer endosomes, which results in influx of counter-ions, swelling and rupturing of endosomal 
membranes and eventual release of cargo into the cytosol (the proton-sponge hypothesis)3,22. This 
explanation has been disputed, however, in favor of an idea that the main contribution for 
endosomal release comes from interactions of polymers with endosomal membranes that results 
in leakage from these vesicles that might be accelerated by the osmotic pressure but not entirely 
dependent on it23,24.   
 Cationic liposomes are very extensively investigated for the delivery of DNA and different 
types of RNA molecules25. Just like in the case of polymers, electrostatic attraction between the 
anionic nucleic acids and the cationic vectors causes a spontaneous formation of complexes. 
Intriguingly, when such complexes were intravenously injected in mice, they elicited inflammatory 
response, but when siRNA and the liposomes were injected separately, the immune response was 
minimal26. The means by which cationic liposomes contribute to the release of cargo to the cytosol 
are still not clear, but it is now accepted that their interactions with anionic membranes of 
endosomes causes the lipid structures to undergo structural change that results in leaking24 or rapid 
release of the nucleic acids from the endosomes8.  
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1.4 RNAi mechanism and location 
The biochemical components that are required to initiate RNAi have been well described. In 
order to degrade mRNA, siRNA combines with argonaute2 protein to create RNA-induced 
silencing complex (RISC). This complex catalytically degrades mRNA molecules that are 
complimentary to the siRNA27. Hitherto, the primary intracellular location of RISC is not well 
known. Processing bodies (also known as p-bodies or GW-bodies) have been detected in various 
locations in the cytoplasm and exhibit accumulation of proteins involved in mRNA degradation 
(including RISC)28. Further observations showed that the formation of the p-bodies might be a 
result of RNAi, and the disruption of p-bodies formation does not inhibit RNAi29. Several studies 
suggest that RNAi machinery might be associated with membranes of LEs and that interference 
with the endosomal maturation process can inhibit RNAi30–32. This might give cells defense ability 
against invading viruses and possibly allow cells to communicate with each other via exosomes 
that originate from LEs30. Still, a recent compelling study followed siRNA delivered by lipid and 
endogenous miRNA and determined that the loading of these RNAs into RISC and subsequent 
mRNA degradation occurs at rough endoplasmic reticulum1. The authors also reported that up to 
90% of initially delivered siRNA is either secreted or degraded 28 h after the transfection, and that 
increase of siRNA concentration during the transfection linearly increased the number of detected 
loaded RISC complexes. They also concluded that only a very small number of these complexes 
(~100) was enough to elicit 50% knockdown of three different mRNAs. Such small numbers of 
active siRNA molecules can explain the difficulty in investigating the internalization and the 
subsequent path of the particles and explain the poor correlation between the uptake and the 
transfection efficiency. Therefore, a closer look at delivery of siRNA-delivering particles is 
required in order to maximize the potential of the siRNA-based medicines.   
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1.5 Challenges and mishaps  
As is evident from this description above, even if the extracellular barriers are not 
considered, the intracellular barriers pose a significant obstacle to the delivery of therapeutics. A 
growing body of evidence suggests only a modest correlation between the accumulation of siRNA-
containing particles in cells and the induced RNAi. The tools and techniques employed to study 
the biology of endocytosis often require skill and understanding of their limitations. For example, 
it has been long believed that one of the endocytosis pathways that is mediated by a protein called 
caveolin-1 leads to the uptake of particles to organelles that are not acidic. However, it is now 
more clear that this pathway was initially mischaracterized, and when it is initiated in non-
endothelial cells, leads cargo to acidic endolysosomal vesicles33. At least part of this 
mischaracterization can be attributed to the attempts to describe the endocytosis through the use 
of chemical inhibitors that are assumed to restrict a specific function of the cells (e.g. acidification 
of endosomes). Nonetheless, this approach did not yield much success, because the specificity of 
the employed inhibitors is rarely proven and is often overstated34,35. Other approaches taken by 
researchers include the expression of dominant negative types of proteins that regulate selective 
functions in cells36–39 or the inhibition of the translation of the regulatory proteins by RNAi-based 
means40–42. Yet, these techniques are based on assumption of highly specific inhibition of limited 
sections of biological processes and ignore the interconnected nature and the intricate complexity 
of the investigated mechanisms such as the endocytosis13,43. Therefore, it is most desirable to study 
endocytosis with the least amount of interference of the biology of the process.  
1.6 Structure of this dissertation 
 In Chapter 2, several conventional techniques will be used in an attempt to quantitatively 
describe the intracellular trafficking of the commonly used polymer-based siRNA particles. A 
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development of a new method to track the kinetics of the internalized particles will be presented, 
and it will be compared against others. In Chapter 3, the newly developed method will be used to 
elucidate the relationship between some of the physical and chemical aspects of the lipid-based 
vectors and their abilities to deliver siRNA. Chapter 4 will present a brief investigation into the 
recycling of the delivered siRNA molecules out of the cells, and an additional investigation into 
the possible intracellular location from which the delivered siRNA escapes to the site of activity 
(cytosol) will be presented. Finally, in Chapter 5 a mathematical model will be used to explore the 
data obtained with the newly developed assay, and a quantitative description of the intracellular 
kinetics of the oligonucleotides delivered by several different vectors will allow to resolve the 
qualitative link between the structures of the delivery vectors and their pharmacokinetics. 
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Chapter 2. Development of methods to investigate endocytosis 
F 
2.1 Introduction 
 It has been long proposed to apply a biomimetic principle to the solutions of drug 
delivery1,2. It could be extremely useful to emulate the ways by which viruses and certain bacteria 
invade cells, but these are very complex organisms. Therefore, a more realistic target could be to 
modify synthetic vectors until their delivery efficacy will begin approaching that of the 
complicated evolved organisms. There are plenty of candidates which can be considered for 
improvement. After all, the first use of a polymer to specifically enhance gene delivery was 
reported in 19653,4. 
Polyethylenimine (PEI) with various modifications has frequently been used in a number 
of clinical trials involving oligonucleotides or DNA delivery5,6. Many of these studies were only 
partially successful, but they revealed the biodistribution, the pharmacokinetics and the toxicity 
profiles of the PEI-based particles. These can be guides to the future developments of these kinds 
of vectors. 
Various explanations have been proposed for the success of PEI as a vector material once 
it delivers the cargo to the cells. It was first proposed that the PEI causes endosomes to burst as a 
result of osmotic swelling7. This allows the delivered nucleic acids to escape before the delivery 
to lysosomes (LYs) where they might be degraded8. However, it was later shown that the 
acidification provided by LYs is essential for release of the material, and the transport to LYs is 
actually a process that in part makes the PEI an efficient vector9. Our group demonstrated a lack 
of correlation between the ability of PEI to deliver DNA and the buffering capacity of the vectors10. 
More recently, it has been shown that the success of PEI as a vector material can be attributed to 
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the interactions between the fraction of the PEI in solution that did not attach to the delivered 
nucleic acid and the biological membranes of the cells11. Part of the difficulty of development of 
synthetic vectors lies in the limited available description of the intracellular kinetics of the vectors 
once they internalize. Therefore, more studies are required to understand what makes PEI and 
other common vectors successful on the intracellular level. 
The tools and techniques employed to study the biology of endocytosis often require skill 
and understanding of their limitations. For example, it has been long believed that one of the 
endocytosis pathways that is mediated by a protein called caveolin-1 leads to the uptake of particles 
to organelles that are not acidic. However, it is now more clear that this pathway was initially 
mischaracterized, and when it is initiated in non-endothelial cells, leads cargo to acidic 
endolysosomal system12. At least part of this mischaracterization can be attributed to the attempts 
to describe the endocytosis through the use of chemical inhibitors that are assumed to restrict only 
a specific function of the cells (e.g. acidification of endosomes). Nonetheless, this approach did 
not yield much success, because the specificity of the employed inhibitors is rarely proven and is 
often overstated13,14. Other approaches include the expression of dominant negative types of 
proteins that regulate selective functions in cells15–18 or the inhibition of the translation of the 
regulatory proteins by RNAi-based means19–21. Yet, these techniques are based on assumption of 
highly specific inhibition of limited sections of biological processes and ignore the interconnected 
nature and the intricate complexity of the investigated mechanisms such as the endocytosis22,23. 
Therefore, it is most desirable to study the endocytosis with the least amount of interference of the 
biology of the process.  
Another common strategy to investigate uptake and intracellular trafficking of endocytosis 
is based on fluorescence microscopy. Even with the wide use of this technique, many researchers 
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fail to acknowledge and account for the numerous limitations of these methods. One of the central 
concerns in the field involves a quantitative analysis of colocalization of fluorescently-labeled 
entities. The particles under investigation are frequently labeled with fluorescent probes and 
delivered to cells. In addition, various intracellular structures are also labeled with fluorescent 
markers by the means of antibodies or expression of fluorescent proteins within their membranes. 
Various microscopes can then be used to determine the degree to which the probes overlap. Some 
suggest that an “intuitive viewing” of the combined images captured by confocal microscope of 
the internalized particles and the intracellular compartments can serve as an evidence for 
colocalization24. To achieve reasonable quantitative estimations, the processing of the samples, the 
calibration of the microscope, the acquisition of the images and their analysis should be done with 
a great amount of expertese25. Unfortunately, there is no consensus on the best practices pertaining 
to these tasks. For example, after an extensive and delicate processing of images from confocal 
microscopy to improve their resolution, some report colocalization of 2 labeled objects to be 
“significant” in the case that over 85% of their shared pixels overlap26, while others27 set this value 
to 40%.  
Cell fractionation is used to separate organelles based on their density differences or 
sedimentation velocities in various media28–30. The locations of particles within different 
organelles can be determined after the organelles have been fractionated based on their physical 
properties. This method is generally considered challenging and requires careful optimization31,32. 
Some researchers attempted to use fractionation to resolve intracellular kinetics of delivered 
nucleic acids, but their efforts yielded limited results33,34. Before the organelles can be separated, 
the plasma membranes of cells should be broken by some mechanical means. This is one of the 
most difficult steps in the process, since the objective is to release cellular organelles without 
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disrupting their membranes. But even if this was diligently accomplished, the identification of 
organelles within the collected fractions is challenging. This is particularly a difficult task when 
the objective is to separate organelles that participate in endocytosis, since they share many 
markers35–37. 
This chapter focuses on the development of methods required to obtain reliable data on the 
intracellular trafficking kinetics of the internalized siRNA complexes. First, confocal microscopy 
and two cell fractionation methods will be explored with a focus on their limitations. Finally, a 
new and simple method will be demonstrated. This method will be applied in the subsequent 
chapters to investigate the relationships between the chemical composition of the vectors and their 
intracellular trafficking.  
2.2 Materials and Methods 
2.2.1 Cells and Nucleic Acids 
HeLaLuc (luciferase-producing cervical cancer) cells were a kind gift from Mark Davis 
group at Caltech. The culture media consisted of DMEM with 10% (v/v) fetal bovine serum (FBS) 
(Gemini Bio-Products, West Sacramento, CA), and the cells were incubated at 37 °C and 5% CO2. 
DMEM and (phosphate buffered saline) PBS were prepared in-house at the Cell Culture Media 
Facility, School of Chemical Sciences, University of Illinois. The cells were cultured according to 
ATCC protocol without antibiotics or fungicides. The luciferase-targeting siRNA, siGL3 (sense 
sequence: 5’-CUU ACG CUG AGU ACU UCG A dTdT-3’) duplex, was purchased from 
Dharmacon (Lafayette, CO). Fluorescently tagged (3’-AlexaFlour647) siRNA and the siRNA that 
was used as a negative control (siNeg) were purchased from Qiagen (Germantown, MD). Red 
florescent protein (RFP)-containing plasmids were obtained from Addgene (Cambridge, MA) 
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plasmid repository. The plasmids were purified using Qiagen MiniPrep system and transfected 
using Lipofectamine 2000 (Thermo Fisher Scientific, Waltham, MA). Addgene plasmids #181738, 
#14436 and #1443739 were used to label organelles in fractionation experiments. Plasmids #13050, 
#1305115, #12661, #12662, #12679 and #1268016  were used in transfections to introduce 
mutations into the proteome of the cells. Unless stated otherwise, all other materials were procured 
from Sigma-Aldrich (St. Louis, MO).  
2.2.2 Polymer 
PEI was used as a model cationic polymer vector. Branched 25-kDa PEI was purchased 
from Sigma and dissolved in purified water at concentration of 1 mg/ml. The stock was kept at 
room temperature prior to being used as a delivery vector. 
2.2.3 Polyplex Formation and Transfection 
 To prepare polyplexes, an appropriate amount of 20 µM stock siRNA in RNase-free water 
was added to PIPES buffer and mixed with an equal volume of PEI solution to give a final weight 
ratio of 10:1 (PEI:siRNA). The particles formed via electrostatic interactions at room temperature 
for 20 minutes before the transfections.  
 HeLaLuc cells were seeded 24 h prior to transfections to achieve ~90% confluency at the 
time of the transfections. For a typical RNAi experiment, 1x105 cells/well were seeded in the 12-
well plates, and the culture media was replaced by 1 ml of serum-free media 30 min prior to the 
addition of 50 µl of the siRNA-particles solution to each well to achieve final concentration of 5 
nM of siRNA. The plates were further incubated for 4 hours at 37 °C and 5% CO2, washed with 
37 °C PBS, and the media was replaced with fresh media that contained 10% FBS (Gemini Bio-
Products, West Sacramento, CA). Twenty hours after the transfection, the cells were washed once 
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with PBS and 100 µl of cell culture lysis reagent (CCLR) were added to each well. Twenty 
microliters of each sample were used to evaluate luciferase expression using Promega luciferase 
assay (Promega, Madison, WI) and Lumat LB 9507 luminometer (Berthold, Oak Ridge, TN) using 
manufacturer’s instructions. The total protein content was evaluated for each sample using Pierce 
BCA assay (Peirce, Rockford, IL) and used to normalize the relative light units (RLU) that 
represented the luciferase content of each sample. 
2.2.4 Uptake Measurements 
 In order to quantify the uptake of siRNA particles, HeLaLuc cells were transfected with 
fluorescently labeled (AF-647) siRNA as described above. A highly sensitive fluorometric 
detection method40 was used in combination with an efficient method41 of removal of cationic non-
internalized particles from cell membranes to determine the amount of internalized siRNA and 
total amount of siRNA that became associated with cells but did not internalize. Briefly, the cells 
were transfected for different time intervals, then half of the samples was washed with ice-cold 
PBS twice while the other half was washed once with an ice-cold solution of 100 IU/ml of heparin 
in PBS followed by a plain PBS wash. The cells were kept on ice during the washing steps to 
prevent internalization or recycling of particles, and each washing step lasted for 5 minutes. The 
cells were then lysed with 200 µl of lysing solution (1% Triton X-100, 2% SDS in PBS) and placed 
on orbital shaker for 30 minutes. Serial dilutions of known siRNA concentration stock were 
prepared in the same lysing solution in black 96-well plates, and 100 µl of each lysate sample were 
added to the plates and diluted with 200 µl of PBS prior to being evaluated using 620/670 nm 
ex/em filters on Tecan Infinite F200 Pro fluorometer (Männedorf, Switzerland). 
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2.2.5 Confocal Laser Scanning Microscopy 
 Intracellular kinetics of polyplex trafficking were investigated using commercially 
available BacMam technology designed to incorporate GFP–tagged Rab5, Rab7 and LAMP1 
proteins into membranes of early endosomes (EE), late endosomes (LE) and lysosomes (LY), 
respectively (Thermo Fisher Scientific, Waltham, MA). HeLaLuc cells were seeded on microscope 
cover slides that were placed inside of 6-well plates at density of 1x105 cells/well. On the next day, 
a 4-hours transfection with the BacMam constructs was performed according to the manufacturer’s 
instructions. The cells were washed with PBS, and allowed to incubate with fresh culture media 
for another 20 hours. The cells were transfected with AF647-labeled polyplexes (final siRNA 
concentration of 5 nM) as described above. The transfections were stopped after different durations; 
the cells were washed twice with ice-cold PBS, once with 0.001% SDS in PBS solution, then once 
with PBS. The cells were then fixed with 3.7% formaldehyde in PBS solution for 5 minutes, 
washed with PBS again and mounted on slides using ProLong Gold Antifade reagent (Thermo 
Fisher Scientific, Waltham, MA) that contained DAPI for nuclear staining. The slides were sealed 
with nail polish, and 10 focal planes were imaged using LSM 700 microscope (Zeiss, Oberkochen, 
Germany) to cover the depth of the cells. Thresholded deconvolution42 was applied to the images, 
and a numerical co-localization analysis was performed using Coloc_2 plugin in Fiji software43 on 
eight separate cells at each time point. To verify the procedure, Mander’s colocalization 
coefficients of computer-generated images with known colocalization values44 were processed in 
a similar manner to the experimentally acquired images. Linear interpolation analysis was 
performed on the computer-generated images, and the mathematical relation of the linear section 
of the graph was applied toward the experimental data to obtain the corrected colocalization values. 
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2.2.6 Isopycnic Fractionation: Optiprep 
 To determine the intracellular traffic of delivered particles, organelles were resolved on a 
pre-formed density gradient. An adapted version of S44 protocol from the OptiPrep manufacturer 
(Axis-Shield, Oslo, Norway) was employed. All of the steps of the procedure were performed on 
ice. HeLaLuc cells were seeded on 100-mm dishes such that 90% confluency was achieved at the 
time of the harvest of the cells. After the transfections, the cells were washed twice with PBS, 2 
ml of homogenization media (0.25 M sucrose, 78 mM KCl, 4 mM MgCl2, 10 mM EGTA, 50 mM 
Hepes-NaOH pH 7.0) were added to cells, and the cells were scraped off the dishes using a rubber 
policeman. Protease inhibitor cocktail containing AEBSF, Aprotinin, Bestatin,E-64, Leupeptin 
and Pepstain A (P8349 at Sigma-Aldrich) was added to cells according to manufacturer’s protocol. 
The cells were then broken using a tight-fit Dounce homogenizer with the number of strokes that 
was previously optimized to be 30.  
For homogenization optimization, a set of 100 µl samples of cell homogenate were 
withdrawn after different number of strokes. The samples were diluted with 0.5 ml of PBS, 25 µl 
were preserved for protein content analysis, and the homogenates were centrifuged at 1000g for 
10 minutes to remove intact cells and nuclei. The supernatants of each sample were compared to 
their corresponding homogenate suspensions with respect to the total protein content using the 
BCA assay.   
  Linear gradients of iodixanol (5 to 35%) were prepared using two programmable syringe 
pumps such that one pump delivered 35% iodixanol solution while the other pump delivered 5% 
solution in 4 mM MgCl2, 10 mM EGTA, 50 mM HEPES-NaOH pH 7.0 buffer. The two solutions 
were slowly delivered at different rates and mixed before they were carefully delivered to the 
bottom of the centrifuge tubes. The 13.5-ml tubes were filled with 12.5 ml of the gradient 
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overlayed with 0.7 ml of the post nuclear supernatants (PNS) from the previous steps. The tubes 
were sealed, placed in a 70.1 Ti Beckman rotor (Brea, CA) and spun at 30000 rpm for 17 h at 4 
0C. The 0.3-ml fractions were manually collected from the top of the tubes by a displacement using 
a saturated sucrose solution, and the density profile was verified by the methods described 
elsewhere45.  
 The determination of the location of endocytic organelles within the iodixanol gradient was 
performed using HeLaLuc cells that were transfected with RFP-containing expression plasmids 
described above. HeLaLuc cells were seeded on 100-mm dishes at 1x106 cells/dish. On the next 
day, the cells were transfected with Lipofectamine2000 in serum-free media with 20 µg of purified 
DNA plasmids. The media was changed after 4 hours, and the cells were further incubated for 48 
hours. Fractionation on iodixanol gradient was performed as described above, and 100 µl from 
each fraction was mixed with 200 µl of PBS in black 96-well plates to monitor the RFP 
fluorescence with 560/635 nm ex/em filter on Tecan Infinite F200 Pro instrument.  The fractions 
from the control group (cells without RFP-constructs) were subtracted from the corresponding 
fractions of groups of cells with RFP-marked membranes. The total resultant fluorescence was 
added for each group and used to normalize each fraction. 
 The density of each collected fraction was determined by an adaptation of a 
spectrophotometric method published previously45. Fifty microliters of each collected fraction 
were transferred to a 96-well plate and diluted with 150 µl of PBS. The absorbance was measured 
at 340 nm using Tecan Infinite F200 Pro instrument. The absorbance values were converted to 
density units by applying a linear regression from a standard curve. 
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 Finally, for the kinetics study, the cells were first transfected with 5 nM AF647-siRNA 
using PEI for different time intervals, and then the isopycnic fractionation was carried out as above. 
The not-transfected cells served as a control for the background fluorescence.  
2.2.7 Sedimentation Fractionation: Percoll 
 Self-generating density gradient colloidal suspension (Percoll) was used to separate 
endocytic vesicles based on their sedimentation rates. The employed protocol is based on a well 
described procedure46–48. Identical procedures of labeling the organelles and transfecting the 
HeLaLuc cells as described above were initially performed. Before the cells were harvested, they 
were washed with ice-cold PBS followed by washing with solution of 100 IU/ml of heparin in 
PBS (HS) and additional PBS wash. The cells were mechanically scraped into 2 ml of 
homogenization media containing 0.25 M sucrose in 10 mM HEPES buffer (pH 7.6) supplemented 
with protease inhibitor cocktail containing AEBSF, Aprotinin, Bestatin,E-64, Leupeptin, Pepstain 
A (P8349 at Sigma-Aldrich). Subsequently, the cells were homogenized with tight-fitted Dounce 
for 30 strokes, and the PNS was generated by centrifugation of homogenate at 1000g for 10 
minutes. Twelve and a half milliliters of 20% or 15% Percoll solutions in homogenization solution 
were placed in 13.5-ml tubes and carefully overlaid with 0.7 ml of PNS. The tubes were sealed 
and spun in a 70.1 Ti Beckman rotor (Brea, CA) at 33000 rpm for 30 minutes at 4 °C. The 0.3-ml 
fractions were collected from the top of the tubes. To measure the total protein content and the β-
hexosaminidase activity in fractions, HeLaLuc cells from four dishes were collected in 2 ml of 
homogenization buffer and fractionated as described above. The 50 µl samples from each fraction 
were mixed with 200 µl of PBS and used in a BCA assay and in the assay that estimates the activity 
of β-hexosaminidase by utilizing the 4-nitrophenyl-N-acetyl-β-D-glucosaminide substrate as 
21 
 
described elsewhere49. The high background absorbance caused by the precipitation of the Percoll 
particles in both of the assays was corrected by control sample that did not contain any cells.  
 To monitor the location of free siRNA and siRNA bound to plasma membranes, two 100-
mm plates of HeLaLuc cells were transfected for 15 minutes with AF647-containing particles. One 
plate was washed with PBS three times, while the washing of the other plate included HS as 
described above. 
 It is common to use either calibrated density beads or refractometers to estimate the density 
of the collected Percoll fractions50. However, a similar protocol that was used for the iodixanol 
gradient was adapted for Percoll. First, the linear relationship between the index of refraction and 
the manually measured density (measured by careful pipetting and taring of empty pipette tips) 
provided by the manufacturer50 was verified. Then a linear relationship between the indices of 
refraction and the absorbance at 340 nm was established. The absorbance at 340 nm of each 
collected fraction was measured as described in 2.2.7 and the established linear relationship was 
used to determine the densities of fractions in g/ml units. 
2.2.8 DAB-Cytometry 
 Polymerization reaction of 3,3'-Diaminobenzidine (DAB), horseradish peroxidase (HRP) 
and H2O2 was used to detect intracellular location of delivered fluorescent polyplexes. HeLaLuc 
cells were seeded in 6-well plates at concentration of 3x105 cells/well. After 20 hours, the culture 
media was exchanged with 2 ml/well of serum-free media 30 minutes before the DAB-cytometry 
protocol depicted in Fig. 1 was carried out with fluorescently labeled 5 nM siRNA transfections 
as described above. To investigate the fraction of delivered siRNA in EEs, the transfections were 
carried out for different time intervals, and HRP at final concentration of 1 mg/ml was added to 
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cells 5 minutes before the end of the transfections. The cells were then washed twice with PBS 
and trypsinized with 500 µl of dye-free trypsin solution. The following steps were performed on 
ice with pre-chilled solutions and microcentrifuge placed in refrigerator. One milliliter of PBS with 
10% FBS to quench the trypsin were added to each well, and the cells were collected into 
centrifuge tubes and spun at 500g for 5 minutes. The supernatant was removed, and cells were re-
suspended in 2 ml of PBS; each sample was split into two new tubes. An additional 1 ml of PBS 
was added to each tube, and the cells were centrifuged at 700g for 5 minutes. The PBS was 
decanted, and 0.5 ml of freshly prepared and 0.4-µm filtered 0.3 mg/ml DAB (in 150 mM NaCl, 
1 mM CaCl2, 5 mM KCl, 1 mM MgCl2, 20 mM HEPES, pH 7.4) solution was added to cells. The 
cells were at 4 °C for 15 minutes, and 5 µl of 3% H2O2 was added to half of the samples. The tubes 
were further incubated for 30 minutes at 4 0C with periodic gentle agitation. One milliliter of PBS 
was added to all of the samples, and they were centrifuged for 5 minutes at 700g. The liquid was 
decanted, and cells were washed again with 1.7 ml of PBS. The pellets were dissolved with 1% 
Triton X-100 in PBS solution, and the tubes were vortexed and placed on an orbital shaker for 30 
minutes. The tubes were vortexed again, and 200 µl of PBS was added. The insoluble fraction was 
pelleted at 17,000g for 30 minutes, and 200 µl of the liquid from the top was analyzed for AF647 
fluorescence as described above. The fluorescence from the samples was converted to siRNA 
concentration using standard curves. The insoluble fraction was computed as a ratio of the siRNA-
AF647 content that got quenched and removed from the supernatant of samples to which H2O2 
was added to the siRNA-AF647 detected in matching samples in which the addition of H2O2 was 
omitted. To label the LYs, the cells were loaded for 30 minutes with HRP with 90 minutes chase 
before the siRNA transfections. To label the entire endocytic system, HRP was added to cells 2 
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hours before the transfection, and the transfection was carried out in the presence of HRP (Figure 
2.1). 
 To verify the DAB-cytometry procedure, cells were seeded in 6-well plates as in the case 
with siRNA delivery experiments, but the 10-kDa dextran conjugated with AF647 fluorophore 
(final concentration 50 µg/ml) was delivered to cells instead of the siRNA. In one case, 30 minutes 
after the change of the culture media to DMEM, HRP and dextran were pre-mixed and delivered 
to cells simultaneously. In another case, the dextran was introduced 30 minutes after the addition 
of HRP. In both cases, cells were further processed as outlined in Fig. 1. 
2.2.9 Production of RNAi-modified cells 
 HeLaLuc cells were seeded in 6-well plates at 3x105 cells/well and transfected on the next 
day with 5 µg of purified DNA plasmids containing either the wild types (WT) or the dominant 
negative types (DN) of Rab5, Rab7 and Rab11 genes. The transfection lasted for 4 hours in serum-
free media with Lipofectamine2000 as directed by the manufacturer. The control included the 
incubation with the Lipofectamine2000 without any plasmid. Two days later, the cells from each 
of the wells were split equally among 6 wells in 12-well plates. After 20 hours in incubator, the 
cells in half of the wells in each group were transfected with 5 nM siGL3 polyplexes and the other 
half with 5 nM siNeg for 4 hours. The measurements of the reporter gene were taken on the next 
day and normalized by the total protein content as described above. The knockdown of Luc gene 
was determined as 1-(normalized Luc expression with siGL3/normalized Luc expression with 
siNeg). 
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2.3 Results 
2.3.1 Kinetics of PEI/siRNA uptake 
 Successful delivery to the cell surface and internalization of siRNA are not always the 
limiting factors in RNAi, but the ability of vectors to mediate these steps should be examined. 
Cationic delivery vectors are attracted and attach to PMs as a result of the anionic proteoglycans 
that are located on the cell surface51,52.  The method employed here was based on the ability of 
heparin to remove complexes that attached to PMs via electrostatic interactions, and it is frequently 
used to wash the cells after the transfections41,53,54. The omission of this washing step allowed for 
the detection of both the internalized and the PM-bound particles, while the washing with heparin 
solution allowed detecting only the internalized portion of the particles. Comparing the 
fluorescence from cells that were not washed to the cells that were washed with heparin provided 
the opportunity to separately detect particles that associated with cells and particles that were 
internalized. The method allowed us to confidently resolve concentrations of AF647-labeled 
siRNA as small as 0.1 nM (Fig. 2.2). This is consistent with the specifications of the fluorescence 
plate reader able to resolve less than 1 pM when measuring fluorescein concentrations55.  
Up to 20% of siRNA that associated with cells was internalized during the 4 hours of 
transfection (Fig. 2.4). The amount of siRNA internalized increased linearly during the entire 
transfection time (R2=0.94). The total siRNA associated with cells was only linear in the first 60 
minutes (R2=0.97) of transfection after which it appeared to reach a plateau.  
2.3.2 Colocalization of siRNA polyplexes with endocytic vesicle marker proteins  
 To identify subcellular location of internalized siRNA/PEI polyplexes, we generated cell 
lines expressing GFP fusions with Rab5 (indicative of early endosomes), Rab7 (indicative of late 
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endosomes) or LAMP1 (indicative of lysosomes) and observed colocalization of siRNA 
fluorescence with these fluorescent proteins.  GFP could be observed in distinct punctuate 
structures within the cells (Fig. 2.4), suggesting the labeling of EEs, LEs and LYs was successful. 
Further processing of the images allowed us to sharpen the images and enhance the quality of the 
colocalization analysis56. Analysis was performed on regions of interest (ROI) on 10 z-slices 
confined within the observed cells. Simple overlap between the color channels that represented the 
polyplexes and endocytic vesicles could only provide a trend of decrease in colocalization between 
EEs and polyplexes during the 4 hours of transfection. The trends were harder to observe with 
labeled LEs and LYs, but the colocalization appeared to peak at 60 minutes with Rab7 GFP-labeled 
LEs (Fig. 2.4). 
 To validate the quantitative analysis, computer-generated images containing pre-set 
colocalized color channels were processed through a freely available co-localization routine. High 
threshold in apparent colocalization data (Mander’s coefficient >0.4) meant that there might be an 
overestimation in actual colocalization when no appropriate corrections are made (Fig. 2.5). This 
overestimation could be a result of threshold setting. Nevertheless, it is consistent with other results 
that used the same computer-generated images on commercially available colocalization 
software44. 
 Colocalization of polyplexes with endocytic vesicle markers was determined for eight cells 
from each group (Fig. 2.6). High colocalization at the beginning of the transfections that was 
decreasing over time in a nearly linear fashion (R2=0.91) could be observed between the delivered 
siRNA and EEs. The colocalization with the LEs marker followed a similar but a less linear trend 
(R2=0.78). Less than 20% colocalization with the lysosomal marker was observed at the beginning 
of the transfections. Colocalization remained nearly constant at 50-60% from 30 min to 4 h. 
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2.3.3 Density-gradient fractionation of siRNA/PEI polyplexes 
 A common technique designed to separate organelles on the basis of their density 
difference was used to quantify the distribution of polyplexes within EEs, LEs and LYs during the 
transfection. A critical step to any fractionation technique is optimization of the cell disruption 
procedure to release internal components. The efficiency of the disruption was evaluated based on 
the total amount of protein that was released from cells after they were broken with Dounce 
apparatus. Fifteen manual strokes released 58% of the total protein, while 30 and 60 strokes 
released 75 and 82%, respectively (Fig.2.7). Therefore, the remainder of the experiments was 
conducted with 30 strokes to avoid excessive disruption of membranes, since doubling the number 
of passages from 30 to 60 only caused only a marginal increase in released cytoplasmic material. 
 Preliminary attempts to use the organelle labeling system that was employed in the 
microscopy studies did not provide meaningful results. The fluorescence of GFP could not be 
detected in the collected iodixanol fractions due to high background fluorescence. Conversely, 
RFP-conjugated Rab5, Rab7 and LAMP1 proteins were expressed in cells to label EEs, LEs and 
LYs, respectively. Longer excitation and emission wavelengths required to detect RFP caused 
much lower background fluorescence of the iodinated media. The long duration of the 
centrifugation (17 h) ensured that the cellular components were separated only on the basis of their 
density, and the density of the gradient was confirmed to be linear in a range between 1.04 and 
1.16 g/ml. The majority of the structures labeled with all of the three markers could be located in 
a broad range between fractions 5 and 25 (Fig. 2.8). The manufacturer suggests (Application Sheet 
S20) that endosomes are expected to be found in gradients between 1.055-1.070 g/ml and as 
“general rule the density of membrane compartments separated on these long-spin iodixanol 
gradients increases in the order PM<EEs<TGN (trans-Golgi network)<cis-medial Golgi<ERGIC 
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(ER-Golgi intermediate compartment) <ER<LEs<LYs.”57 Since the main peak that included all of 
the markers corresponded to density range of 1.06-1.09 g/ml, it is likely that it represents 
endosomes and not PM or broken vesicles.  
 Kinetics study in which transfections with AF647-siRNA at different durations were 
conducted prior to iodixanol separation procedure was carried out. Again, most of the fluorescence 
was detected between 1.06 and 1.09 g/ml within the gradients (Fig. 2.9). However, it can be noted 
that in fractions 5-10 no variation in fluorescence as a function of transfection duration was 
observed. This suggests that these fractions represent early stations within the endocytosis (PM, 
EEs). The fluorescence in fractions 10-15 increased between 5 and 15 minutes, but the increase 
slowed down after that. This is in contrast to fractions 20-25 that show almost no difference 
between 5 and 15 minutes of transfection but then reach steady state after 30 minutes. Therefore, 
it can be inferred that some separation of the organelles occurred, and the general density banding 
order was observed. However, this was not enough to quantify the kinetics. 
2.3.4 Sedimentation density-gradient fractionation of siRNA/PEI polyplexes 
 Percoll gradient was used to separate organelles based on their density and size. The 
suspensions of broken organelles were layered on 15 or 20% Percoll solutions, and the density 
profiles of the collected fractions are shown in Fig. 2.10. The cells were again labeled with the 
RFP-based markers of EEs (Rab5), LEs (Rab7) and LYs (LAMP1). LAMP1-RFP-based labeling 
showed migration of the LYs to the bottom of 15% Percoll gradient (Fig. 2.11) and to fractions 
38-42 in 20% gradient (Fig. 2.12).  The majority of all three RFP markers was found at the top of 
the gradients, but that can represent PM fractions, broken organelles fractions or simply the RFP 
constructs that did not integrate into internal membranes. Plotting the ratio of Rab7/Rab5 helped 
to identify LEs within the gradient (inlays in Figs. 2.11 and 2.12). This ratio peaked at fractions 5 
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and 9 in 15 and 20% gradients, respectively. The Rab5 and Rab7 fluorescence were only slightly 
above the background level in fractions denser than the 10th, so their ratio values are not reliable 
indicators beyond that fraction. β-Hexosaminidase (marker of LYs) peaked at the top of the 20% 
gradient and at fractions 34-40 (Fig. 2.13). Taking into account that equal volumes of the fractions 
were used for this assay and that most of the protein from cells could be located at the top of the 
gradient (Fig. 2.14), the assay indicated that lysosomal fractions were located at the bottom of the 
gradient. 
 To identify the location of siRNA complexes that were only weakly bound to PMs or not 
contained inside the vesicles separated on 20% Percoll gradient, two dishes of HeLaLuc cells were 
transfected for 5 minutes with PEI/siRNA. Subsequently, one dish was washed with HS solution 
as described above, while this step was replaced by a PBS wash, which does not remove PM-
bound polyplexes, in the other group. The cells were then collected, broken, and their contents 
were resolved on 20% gradients. The results indicate that the PM-bound and free siRNA particles 
could be mostly located within the top two fractions of the gradient (Fig. 2.15). 
 HeLaLuc cells were transfected with fluorescently labeled polyplexes for different 
durations, and the sedimentation-based Percoll separation was used to investigate intracellular 
trafficking. The background corrected fluorescence of the collected fractions indicated three 
distinct regions within the gradients (Fig. 2.16). Fractions 38 to 42 contained little siRNA in the 
first 15 minutes of the transfection, but at 30 minutes and above the amount of siRNA in these 
fractions progressively carried as usualy increased. Fractions 11 to 17 showed initial increase in 
siRNA content for the first 30 minutes, but this process slowed down and stopped at later times. 
These fractions likely contained Rab7-enriched late endosomes. The first five fractions collected 
from cells that were transfected for 5 min contained over 45% of the siRNA. However, these 
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fractions also represent siRNA released from unintentionally broken organelles, plasma 
membranes and cytosol. Considering the results that demonstrated that the two lightest fractions 
could contain both the PM-bound and the free-floating polyplexes, EE-enriched fractions were 
defined as the ones between fraction 3 and 11. Adding these three regions within the gradients 
results in ~60% of the total detected siRNA at each measured time. 
To summarize, 44% of polyplexes were located within EEs 5 minutes post-transfection, 
but this value rapidly decreased and appeared to achieve steady state 25 minutes later. Less than 
8% of polyplexes were located within the LEs at 5 minutes time point, this value spiked to 18% 
10 minutes later and quickly stabilized at 13% for the remainder of the transfection. Less than 10% 
of the particles reached LYs at 5 minutes, and their fraction of total detected particles steadily 
increased during the first 60 minutes to 25% and dropped by less than 4% during the next hour 
(Fig 2.17).  
2.3.5 Comparative kinetics-based investigation 
 A procedure that allowed the investigation of the intracellular trafficking kinetics of the 
delivered polyplexes relative to the kinetics of HRP was established.  HRP is a well described 
marker of fluid phase pinocytosis; it follows endolysosomal path upon the internalization, and its 
activity is restricted to internal vesicles until it reaches lysosomes where it slowly degrades58. DAB 
and H2O2 can readily cross biological membranes, and when they reach intracellular vesicles that 
contain HRP, they initiate a free-radical polymerization reaction within the lumen of these vesicles 
that become crosslinked. Several important properties of this process can be explored. The 
crosslinked vesicles trap their contents and become relatively dense59 and insoluble to detergents60. 
This makes the isolation of these vesicles and their contents a simple task. In addition, DAB 
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polymerization causes quenching of fluorescence from fluorophores trapped within the vesicles61–
63.  
The adapted protocol64,65 was to detect the amount of the fluorescently-labeled polyplexes 
that became trapped within the crosslinked vesicles. Upon delivery to cells, HRP is confined to 
EEs within the first 5 minutes, then it progresses to LEs and reaches LYs within an hour66. Thus, 
HRP was used as a kinetics-based marker of different transport stages. Co-introduction of 
polyplexes and HRP to cells at different relative time points allowed for the detection of delivered 
siRNA within EEs, LYs or the total endolysosomal pathway as a fraction of the total internalized 
siRNA. To detect this fraction within EEs, siRNA transfections were performed as usual, and HRP 
was added 5 minutes before the transfections stopped. To detect the siRNA fraction located in LYs, 
the cells were first pre-loaded with HRP for 30 minutes, then only after at least 90 minutes chase 
period the siRNA transfections were carried out. To determine the fraction of siRNA located 
within all of the internal endolysosomal vesicles, HRP was introduced to cell media at least 2 hours 
before the siRNA transfections began and remained in the media until the transfections were 
terminated.  
At desired times post-transfection, the cells were collected, washed, loaded with DAB 
monomers and split equally into two tubes. H2O2 was then added to one of the tubes. The 
polymerization caused the siRNA that was colocalized within the same vesicles as the HRP to 
become trapped and their fluorescence was quenched. At the same time, the tube to which H2O2 
was not added served as control. Cells in both of the tubes were lysed with detergent that readily 
dissolved intracellular membranes that were not crosslinked. The trapped siRNA was then 
removed from cell lysate with simple centrifugation, and the AF647 fluorescence from the 
31 
 
supernatant was compared to the fluorescence control to provide the insoluble fraction values via 
the following relation: 
𝐼𝑛𝑠𝑜𝑙𝑢𝑏𝑙𝑒 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 = 1 −
𝑠𝑖𝑅𝑁𝐴 𝑖𝑛 𝑡𝑢𝑏𝑒 𝑖𝑛𝑐𝑢𝑏𝑎𝑡𝑒𝑑 𝑤𝑖𝑡ℎ H2𝑂2 
𝑠𝑖𝑅𝑁𝐴 𝑖𝑛 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 
The siRNA transfections lasted for various time intervals, so the resultant insoluble fractions 
represent the fractions of delivered siRNA in different compartments at different time points (Fig. 
2.18). Approximately 59% of siRNA was located inside of the EEs 5 minutes after the transfections; 
this value rapidly dropped to 20% 25 minutes later, remained nearly constant for the next hour and 
dropped to below 5% 3 hours after the transfections. siRNA was first detected in LYs 30 minutes 
after the beginning of the transfection and its fraction increased by only 4% in the next 90 minutes 
and by additional 16% during the last hour of the transfections. When the entire endolysosomal 
pathway was loaded with HRP, 60% of siRNA colocalized with HRP at 5 min point; this increased 
to 81% and remained stagnant until the end of the transfections.  
 To test whether the fluorescence quenching and vesicle crosslinking was limited by the 
type of fluorophore or the concentration of HRP, dextran conjugated to AF647 was delivered 
instead of polyplexes either simultaneously with HRP or 30 minutes after the HRP was introduced 
to cells. Both dextran and HRP are commonly used markers for fluid-phase endocytosis that are 
not rapidly recycled. As HRP enters the cells, it first travels to the EEs using primary endocytic 
vesicles. The concentration of HRP in early endosomal compartment then rises until the EEs stop 
accepting incoming cargoes and mature to LEs.  Similar behavior is expected in the subsequent 
endocytic compartments. The 30 minutes preload with HRP ahead of dextran should have been 
sufficient for the saturation of the compartments with HRP before the arrival of dextran. Since the 
crosslinking efficiency did not vary substantially between the two groups (Fig. 2.19), it is evident 
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that the concentration of HRP within endocytic compartments does not influence the crosslinking 
efficiency by more than ~5%. Assuming that dextran does not have capacity to escape from the 
endolysosomal vesicles35, the comparison between the highest insoluble/trapped fraction of 
dextran and delivered PEI reveals that only up to 10% of PEI that entered the cells was not within 
internal membranes at the later stages (>30 minutes) of the transfections. This fraction was ~25% 
at the beginning of the transfections. This might be counterintuitive, but the total number of 
internalized particles continues to increase throughout the experiment, so the number of non-
vesicles-enclosed particles increases as well. 
2.3.6 Effects of alteration of endocytosis on RNAi 
 To clarify the impact of intracellular trafficking of polyplexes on induced knockdown, the 
HeLaLuc cells were transfected with plasmids that coded for either the wild type (WT) or the 
dominant negative (DN) forms of key proteins that govern different endocytic steps. These 
plasmids have an established record of their effect on endocytosis. Expression of Rab5DN has 
been shown to inhibit internalization of cargo by clathrin-mediated endocytosis pathway into EEs 
but not to interfere with clathrin-independent internalization into the same EE compartment15. 
Rab7 has been shown to regulate traffic in and out of the LEs, and expression of Rab7DN was 
demonstrated to reduce degradation of ligand (EGF) that is a typical marker for cargo traveling to 
LYs from LEs through EEs16. Expression of Rab7DN was shown to result in an increase of the 
size of the EEs39 while the knockdown of Rab7 with siRNA was demonstrated to result in 
disruption of cargo transfer from LEs to LYs67. Expression of Rab11DN interferes with 
progression to recycling endosomes15, and Rab11 can be used to define recycling endosomes, but 
it has many functions and can interact with numerous proteins68.  
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Expression of any of the three DN-type proteins resulted in a dramatic decrease in induced 
RNAi (Fig. 2.20). The knockdown achieved in the control group was 34% and the expression of 
Rab5DN, Rab7DN and Rab11DN caused it to drop to 11, 6 and 5%, respectively. The expression 
of Rab7WT and Rab11WT but not of Rab5WT also significantly hindered the RNAi. The 
expression of Rab5DN and Rab7DN but not of Rab11DN reduced knockdown by more than the 
expression of their WT-counterparts. This demonstrates the high degree of influence of 
endocytosis on successful delivery of nanoparticles, but a single limiting factor of successful 
delivery could not be established with this technique. This experiment demonstrates that an attempt 
to alter a single step in endocytosis will likely lead to alterations in others steps and inconclusive 
results. Hence, in order to study the endocytosis of particles, it is most desirable to not employ 
such techniques.  
2.4 Discussion 
 The topic of endocytosis of particles is central to the development of effective 
olionucleotide-based medicines. The bulk of the research is focused on the ability of the vectors 
to facilitate the release of the internalized cargo from the endosomes. However, this process is not 
easy to observe or to describe. Numerous hypotheses that attempt to describe the interactions of 
vector materials with internal membranes yielded only limited guidelines for the structure of 
effective materials. It is impossible to clearly define the link between the chemical structure and 
function of the vectors without sufficient data that describes the fate of the internalized particles. 
Therefore, the cornerstone of the current work was in the development of methods that allowed 
tracing the path of the internalized particles. 
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 The ability of particles to reach PMs largely depends on the charge of the particles. Cationic 
particles have advantage over other types, since the initial interaction with cells largely depends 
on anionic membrane-associated proteoglycans69. Once the particles reach the cell surface, they 
can either interact with various receptors and proceed with endocytosis or internalize by directly 
inducing deformations in biological lipid membranes23. In the case of the investigated system, the 
association of polyplexes with PMs was increased in a linear manner in the first 60 minutes of 
transfection, but it considerably slowed down as the transfections progressed.  The internalization 
of polyplexes occurred in a linear manner for the duration of the entire transfection periods. This 
suggests that the particle-cell contacts are limited by the physical number of interaction sites on 
the cells. The constant rate of the internalization indicates that the predominant endocytosis 
pathway was not limited by the availability of various sites of endocytosis receptor clusters on the 
PMs. The amount of PEI used was in excess of the relative amount of siRNA that is required to 
form particles via electrostatic interactions70. The excess of PEI in solution has been attributed to 
the main success of PEI in the case of DNA transfections11. In addition, nanoparticles have the 
ability to deform lipid membranes and to induce complete invagination simply as a result of their 
physical properties23. Combined with the ability of PEI to destabilize biological membranes71, this 
opens up a possibility for a significant amount of polyplexes that entered the cells not through a 
regulated endocytic mechanism (usually limited by the number of active receptors on cell surface), 
but by a direct penetration of PMs.  
 Confocal microscopy can be an effective method of investigation into many biological 
processes. However, it should be used with extreme caution, since it often leads to inconsistent 
and subjective results72. The most common way to represent colocalization observed by 
fluorescence from different molecules includes their simple presentation in a pseudocolored image. 
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The visual overlap between the color channels is often taken as an evidence of spatial 
colocalization. However, this approach is often problematic, since it excludes the consideration of 
the depth of the specimen. In addition, such approach is valid strictly “when the fluorescence of 
the two probes occurs in a fixed and nearly equal proportion.73” Overall, it can be concluded that 
there is “a lack of reliable methods to visualize and quantify” the intracellular trafficking of 
nanoparticles27. Even if several z-layers are explored, and careful threshold and deconvolution are 
performed, the resolution of most confocal microscopes is only sufficient to track large aggregates 
of fluorescent particles27. The visual representation of colocalization between polyplexes and three 
labeled types of vesicles could at best provide the general trends in colocalization of delivered 
particles and internal compartments (Fig. 2.4). More importantly, the images represent the fact that 
the labeled internal organelles construct a very dense network that can easily overestimate the true 
colocalization values. When the computer generated images were applied to the employed 
colocalization routine, there was an apparent high threshold value (~0.5) of the Mander’s 
colocalization coefficient (MCC) after which the actual colocalization could be detected (Fig. 2.5). 
This coefficient represents the fraction of colocalized pixels in the total number of pixels of one 
color. However, as the overall number of pixels of one color grows, there is an increased chance 
of an apparent overlap even if the two labeled structures are not spatially colocalized. Therefore, 
statistical significance should be employed in conjunction with different colocalization 
coefficients to determine that the overlap is not occurring by chance73.  
Even though this analysis was not performed in this work, an attempt to compensate for 
this issue was made by constructing a correlation between the MCC and actual colocalization (Fig. 
2.5). The MCC was used because it is intuitive and convenient, since it ranges from zero (no 
overlap) to one (complete overlap). Unlike other colocalization coefficients, MCC is not dependent 
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on the relative fluorescence intensities of the investigated objects, so there are strong suggestions 
about it being the most appropriate quantitative colocalization parameter when dissimilar objects 
such as polyplexes and endosomes are spatially correlated74. The appropriate conversion from 
MCC to actual colocalization revealed that the colocalization patterns between the particles and 
the EEs and between the particles and LEs (Fig. 2.6) are very similar. This could be the result of 
the biochemical similarity between the membranes of EEs and LEs. To put it simply, the Rab-GFP 
markers did not label the vesicles specifically. The fluorescent labeling of LAMP1 gave an 
impression that up to 60% of delivered particles reached LYs 30 minutes after the transfection 
began. However, this and the subsequent pattern of slow increase in colocalization with LYs are 
difficult to accurately quantify because of the high errors resulting from small sample number (8 
cells for each point).  
In summary, the employed fluorescence microscopy techniques could not provide 
sufficiently accurate and reliable data for a robust mathematical description of the intracellular 
trafficking kinetics. This is not an uncommon result. One study that also attempted to decipher the 
intracellular trafficking of polyplexes in HeLa cells and included multiple advanced aspects of 
spatial correction of acquired confocal 3-D images (i.e., deconvolution with experimentally 
determined chromatic shift corrections) resulted in only general trends sufficient to compare 
kinetics (three time points) of two polymer vectors74. 
 As an alternative to microscopy, the physical properties of different endocytic vesicles 
might be used for their separation. For example, isopycnic gradient fractionation separates vesicles 
based on their density. The terminal settling velocity of a sphere in fluid is proportional to the 
difference in density of the settling sphere and the surrounding media and to the square of the 
radius of the sphere75. Accordingly, regardless of the size of the separated organelles 
37 
 
(approximated as spheres), they stop migrating through the density solution when their density 
equals the density of their surroundings. The drawbacks of isopycnic fractionation are that the long 
centrifugation times required can result in higher aggregation and breakage of separated vesicles. 
While some researchers76,77 have demonstrated remarkable separation of different types of 
endocytic organelles in this type of  Iodixanol gradient, others33,34 reported difficulties in achieving 
the separation. In this study, no quantifiable information regarding the endocytosis of polyplexes 
could be extracted from the isopycnic fractionation on Iodixanol gradient. Among others, the lack 
of separation could be a result of either excessive breakage of internal vesicles, similarity in the 
density of different organelles or insufficiently unique markers (Rab proteins and LAMP1) that 
were used to identify the fractions.  
Another attempted centrifugation technique to separate organelles involved self-generating 
density gradient (Percoll). The centrifugation time was shorter than in the procedure with Iodixanol, 
so it is likely that the separation was based on both the hydrodynamic size of the vesicles and their 
density. Fractionation on top of the 15% Percoll gradient (Fig. 2.11) resulted in a broader LEs 
(Rab7-enriched) peak compared to the fractionation on a denser 20% Percoll media (Fig. 2.12). 
The heavy LAMP1-enriched peak appeared at the bottom of the 15% Percoll gradient compared 
to the 20% gradient where it appeared seven fractions from the bottom of the tubes. Since the 
objective was to quantify fluorescent siRNA in different peaks within the gradients, 20% Percoll 
was used for the remainder of the study to avoid summation of fluorescence over a greater number 
of fractions and avoid losing data on some LYs that could sediment to the bottom of the centrifuge 
tubes in the 15% Percoll gradient.  If siRNA was reaching cytosol by escaping from the internal 
vesicles or by direct penetration through PM, then it would mostly be located in the first couple of 
fractions within the gradients. However, these fractions were “contaminated” with siRNA released 
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as a result of a harsh cell homogenization procedure as evidenced by the high β-hexosaminidase 
activity (Fig. 2.13) and high levels of detected RFP-labeled proteins. The origin of the siRNA in 
these top fractions could not be elucidated with the employed fractionation protocol.  
“The maturation model” of endocytosis states that organelles involved in endocytosis are 
distinct but mature into the subsequent organelles along the pathway. The competing but less 
popular “pre-existing compartment” model of endocytosis describes endocytic organelles as more 
stationary and complex entities that exchange cargoes through small vesicles37. Since experimental 
evidence exists to support both of the models, some hypothesize that the actual biology is likely a 
combination of both endocytosis models78. If this is indeed the case, then there should be a 
significant pool of small siRNA-containing vesicles in the PNS originating from the cargoes 
exchange between the compartments. Perhaps this also contributed to the high levels of siRNA 
and RFP molecules that were detected in the several lightest fractions within the gradients. 
Even though the separation resolution was limited, some quantitative kinetics data could 
be extracted (Fig. 2.17). The amount of siRNA molecules in the heavier and the lighter fractions 
continued to increase throughout the experiment. In order to calculate meaningful values for the 
fractions of the siRNA within intracellular compartments, the background-subtracted fluorescence 
in the regions within the gradients representing these compartments was summed. These sums 
were normalized to the summed fluorescence of the entire gradient excluding the first two fractions. 
The resulting data indicate an approximately steady state level of internal trafficking between EEs 
and LYs established ~60 minutes after the transfections. Still, the data only describe ~60% of the 
detected siRNA, and the identified representative regions within the gradients might include other 
organelles that participate in intracellular trafficking (recycling endosomes, autophagosomes, 
hybrid vesicles, Golgi, ER, etc.). Compared to microscopy, the advantages of fractionation are in 
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the large number of cells that are represented in each experiment and in a higher certainty that the 
measured fluorescence comes not only from aggregates but from all of the delivered siRNA.  
 The DAB cytochemistry method that allows for an increase in resolution of separation of 
endocytic vesicles in density gradients was first published over 30 years ago59. The procedure 
involves a density-shift of endosomes in which a DAB polymerization reaction, catalyzed by 
peroxidase, has occurred. As was demonstrated in the centrifugation experiments described above, 
the native density of endosomes is not always sufficient to separate them from cytosol and broken 
membranes. The denser lysosomes were relatively easy to separate.  In addition, DAB 
polymerization reaction renders intracellular vesicles resistant to detergent and quenches 
fluorophores located within the vesicles. The density-shift technique is part of the density gradient 
fractionation that typically involves mechanical disruption of cells to release the internal organelles. 
This procedure can be challenging to reproduce. For example, even limited amount of DNA 
released by broken nuclei can act as “glue” and create gel-like aggregates that will interfere with 
the separation79,80. The density-shift can be carried out after or before the cell cracking procedure, 
but the potential issues encountered with mechanical membrane disruption are not avoided in 
either of the cases. DAB cytometry procedure can be carried out without density gradient 
purification with the ability to separate vesicles that contain HRP enzyme without disturbing other 
internal organelles. Once the polymerization reaction is carried out, the separation of the 
crosslinked vesicles can be done on the basis of their insolubility in detergents as was carried out 
in this study.  
The amount of delivered siRNA trapped in insoluble vesicles was found by comparing the 
samples to the controls in which the crucial step of H2O2 addition to promote the DAB 
polymerization was omitted. Even though the bulk of the crosslinked vesicles were eliminated 
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from the cell lysates by simple centrifugation, great stability of the AF647 fluorophore that was 
used to detect siRNA could limit the application of the DAB-cytometry technique. Nevertheless, 
the quenching of the fluorescence within the lumen of the polymerized vesicles could provide 
additional sensitivity to the assay, and make it less reliant on the detergent lysing or the 
concentration of the reactants involved in the polymerization. This was not directly tested by the 
experiments, but since over 90% of AF647 fluorescence was eliminated in the experiment in which 
AF647-conjugated dextran was delivered (Fig. 2.19), the quenching could have been one of the 
factors contributing to the success of this assay.  
 The DAB cytometry assay provided kinetics data of the polyplexes in the EE and LY 
compartments (Fig. 2.18) very similar to those obtained with Percoll gradient centrifugation 
experiments. The fraction of the siRNA in EEs quickly dropped from 59% to 20% in 25 minutes 
after the transfections and did not significantly change until >120 minutes post-transfection. The 
59% of polyplexes localized in EEs at the first measured point (5 min) should be considered in the 
context of the maximum possible crosslinking that could be achieved if the total endolysosomal 
system was loaded with HRP, which was 60%. A couple of mechanisms could potentially explain 
why no more than 60% of the siRNA could be crosslinked. A significant fraction of polyplexes 
could enter the cells though direct penetration of PMs81 thus avoiding being trapped in internal 
vesicles. Also, at early endocytic stages HRP and polyplexes could follow different endocytosis 
pathways, but would likely be found in the same EEs within ~5 minutes after the internalization78. 
This can be reinforced by the fact that over 85% of the delivered dextran was detected in the 
vesicles that also contained HRP 5 minutes after both were simultaneously introduced to cells (Fig. 
19). Both dextran and HRP are similar types of pinocytic endocytosis markers that readily enter 
cells through either non-receptor mediated pathways (i.e. micropinocytosis) or a combination of 
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different pathways82–84. Nanoparticles formed of cationic polymers, however, are more likely to 
enter cells through a more specific pathway and will enter the endolysosomal system12.  
The dynamics of entrance of polyplexes into LYs observed with fractionation experiments 
was similar to that observed by the DAB cytometry. The HRP/DAB assay appears to provide more 
accurate data, since it is not reasonable to expect 10% of delivered particles to reach LYs only 5 
minutes after the delivery as was observed with fractionation. Both of the techniques provide a 
nearly steady-state rate of entrance of polyplexes into LYs during the second hour of transfections 
(Figs. 2.17 and 2.18). The kinetics of particles 3 hours post-transfection were only evaluated with 
DAB cytometry and revealed a sharp increase in fraction of particles in LYs and a rapid decline in 
the EE compartment. This could be explained by either particles following multiple intracellular 
pathways on their way to LYs, or by the existence of hybrid LE/LY compartment that steadily 
accepted particles during the second hour of transfections from LEs and began transferring the 
cargo to LYs during the third hour. Mechanistically, besides the well described endolysosomal 
maturation, the particles could be delivered to LYs via autophagy from cytoplasm after escaping 
from endosomes or after entering the cells through a non-endocytic pathway85. This process could 
be slower than the typical endolysosomal degradation pathway and began providing delivered 
material to LYs 2 h after the delivery. Alternatively, since a 30 minutes pulse of HRP was used to 
mark the LYs, it is possible that not all HRP reached LYs at various times when the crosslinking 
was performed. It is well known that HRP is accumulating in LYs58, but if the transition between 
the hybrid LE/LY vesicles to terminal LYs is particularly long, then the DAB polymerization could 
trap delivered siRNA in both the pre-lysosomal and lysosomal compartments. Experimental data 
indicated that the detected increase in amount of siRNA in LYs between 2 and 3 h was not the 
result of insufficient concentration of HRP in LYs. If the HRP concentration got only high enough 
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to allow the detection of siRNA at that compartment two to three hours from the beginning of the 
transfections, then a sharper jump in the “insoluble fraction” during the same period in the samples 
with the fully HRP-loaded endolysosomal system would have been observed (Fig. 18). In fact, 
since similar crosslinking efficiency was observed when AF647-labeled dextran was delivered to 
cells either simultaneously or 30 minutes after the HRP was introduced, the concentration of HRP 
within the endocytic compartments did not substantially affect the experimental outcomes (Fig. 
19). The great sensitivity of the DAB cytometry was demonstrated by a very elegant study by 
Stinchcombe et al., which showed that a single HRP molecule entrapped in 60-80 nm liposomal 
vesicles could be sufficient to fill the entire lumen with DAB polymerization reaction product86.  
To highlight the importance of the intracellular trafficking kinetics on the performance of 
a vector, the cells were transfected with vectors expressing DN or WT forms of proteins that 
govern different endocytosis steps. Certainly, the biochemical mechanisms by which siRNA 
promotes knockdown have been well explored and described87. Yet the question of the location 
within the cytoplasm where RNAi process occurs has not been elucidated. Processing bodies (also 
known as p-bodies or GW-bodies) have been detected in various intracellular locations and exhibit 
accumulation of proteins involved in mRNA degradation88. Further observations showed that the 
formation of the p-bodies might be a result of RNAi, and the disruption of p-bodies formation does 
not inhibit RNAi89. Several studies suggest that RNAi machinery might be associated with 
membranes of LEs and that interference with the endosomal maturation process can inhibit 
RNAi90–92. Alternatively, it has been reported that mRNA degradation resulting from siRNA 
delivery occurs at rough endoplasmic reticulum93. The presented results (Fig. 20) suggest that the 
activity of EEs is highly influential in the subsequent siRNA delivered by PEI. Overexpression of 
Rab7WT could have promoted the movement of the siRNA to LYs or other terminal vesicles, 
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while Rab7DN could alter the EE functions, by perhaps preventing normal fusion of endocytic 
vesicles with EEs. Since recycling endosomes are essentially products of EE maturation68, it is 
possible that overexpression of either Rab11DN or Rab11WT influenced the normal biological 
function of EEs and prevented RNAi to take place. Rab11 is largely associated with slow recycling 
from REs and Rab4 with fast recycling from EEs. Expression of DN form of Rab4 showed 
inhibition of fast recycling route, while knockdown of Rab4 upregulated the rapid recycling with 
a possible explanation of the Rab4 knockdown leading to reduction of EE to RE traffic68.  Perhaps 
the overexpression of Rab11 led to increase in slow recycling while expression of Rab11DN 
inhibited the slow recycling which was compensated by an increase in the faster recycling from 
EE to PM. The results are consistent with an idea that the RNAi machinery is directly associated 
with endosomal trafficking91. 
2.5 Conclusions 
 Several common experimental techniques were used to assess the intracellular trafficking 
kinetics of siRNA delivered by PEI. The limitations of the fluorescence microscopy colocalization 
are mainly due to the complexity of the densely-packed cytoplasm, inherent physical limitations 
of microscopy and lack of control samples. Quantitative and qualitative analyses of colocalization 
should include a proof that the coincidence of random overlap between the explored probes has no 
substantial impact on the reported results. Complicated statistical algorithms exist to prove the 
degree of significance of the observed overlap73. Still, they are difficult to implement by the end-
user, since they include assumptions about the nature of the evaluated fluorescence probes and 
experimental conditions that are challenging to experimentally confirm. Confocal microscopy 
greatly increases the axial resolution of the obtained images, but it also reduces the signal-to-noise 
ratio, since the small size of the pinhole used in the microscopes to filter out out-of-focus light also 
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causes less light from the probes to reach the detectors73. The practical advantage of this 
phenomenon is that it allows one to discriminate between large aggregates of delivered particles 
that appear as a punctuate pattern and free molecules that are not bound by intracellular 
membranes94 .  
Similarly, the task of investigation of the release of the molecules from internal vesicles to 
cytosol or direct penetration of the delivered particles to cytosol avoiding the endocytosis is 
challenging to achieve with density fractionation methods. These involve mechanical steps that 
may break some of the internal vesicles leading to an over estimation of the amount of particles in 
cytosol. As with the confocal microscopy, fractionation relies on biochemical markers of 
organelles. Even though endocytosis is a highly organized process, no known biochemical markers 
exclusively identify one kind of endocytic vesicle95. Still, there are many steps that can be taken 
to optimize the fractionation: cell cracking methods, number of separation steps, density and type 
of gradient media, centrifugation conditions, etc29,49,96. The typical tradeoff between the purity and 
the recovery efficiency associated with separation processes is also applied to the fractionation. It 
might be of interest for cell biologists to obtain high purity sample of certain type of organelles to 
study their biochemistry, but the overall recovery of these organelles will likely be too low for 
endocytosis kinetics studies34. Compared to microscopy, it is typically easier to study a large 
number of cells with fractionation assays. Therefore, the two techniques can be complimentary to 
each other in the hands of an experienced researcher.  
 The DAB cytometry procedure described above provided simpler and faster means of 
resolving the intracellular kinetics compared to subcellular fractionation and microscopy. The 
latter two techniques can be most useful when directly comparing performance of different vectors, 
but DAB cytometry introduces additional reference in the form of a well characterized pinocytosis 
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marker (HRP) against which the investigated vectors are first compared. Inasmuch as this adds a 
degree of complexity, DAB cytometry requires less optimization and less specialized skills while 
providing a more complete representation of the kinetics in intracellular compartments in the 
context of the whole endocytosis system. The developed method revealed that the fraction of 
internalized PEI particles not within the endolysosomal vesicles is higher in the first 30 minutes 
of the transfections than after that, and this fraction is nearly constant between 60 and 180 minutes 
after the beginning of the delivery. The overall uptake rate of particles was constant, so the 
polyplexes are not released into cytosol from LEs or LYs in a substantial manner. Hence, the 
success of PEI as a vector material could be due to its ability to either deliver siRNA directly to 
cells avoiding endocytosis or promoting escape from EEs. But since the experiments with the 
mutant cells revealed the importance of endocytosis and EEs to induced RNAi knockdown, it is 
the ability of PEI to promote the escape of siRNA from EEs to cytosol that makes it an effective 
vector material. 
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2.7 Figures 
 
Figure 2.1. Outline of the DAB-cytometry protocol (A). Photograph of the tubes containing cell 
pellets after the DAB polymerization reaction: the one on the left contained H2O2 and the cell 
pellet looks darker than the one on the right into which H2O2 was not added (B). (C), (D) and (E) 
are schematic representations of procedures used to determine siRNA content in EEs, LYs and 
complete endolysosomal pathway, respectively. 
 
Figure 2.2. Standard curve used to determine siRNA concentration. 
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Figure 2.3. siRNA uptake in HeLaLuc cells upon transfection with PEI/AF647-siRNA 
polyplexes measured by fluorescence of cell lysate at various times post-transfection. The cells 
were washed with either PBS or a combination of PBS and HS solution to remove non-
internalized polyplexes, and the total siRNA uptake was measured in cell lysates. N=4, Error 
bars represent s.d. 
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Figure 2.4. Representative images of HeLaLuc cells expressing GFP fusions with markers of 
endocytic vesicles and transfected with PEI/AF647-siRNA polyplexes generated by 
A 
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deconvolution and addition of 10 z-slices of the original photographs used in the colocalization 
study. EEs (A), LEs (B) and LYs (C) represented in green and marked with GFP-tagged Rab5, 
Rab7 and LAMP1, respectively. Red represents siRNA polyplexes. The b&w pictures represent 
colocalized pixels. All images are 203 X 203 µm. 
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Figure 2.4. Continued 
B 
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Figure 2.4. Continued 
 
 
C 
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Figure 2.5. Computer-generated images of pre-set colocalization of two color channels were used 
to calibrate the analysis: only the linear portion of the relationship (>20% colocalization) was 
used as a reference to convert Mander’s coefficients to colocalization values. 
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Figure 2.6. Colocalization of AF647-siRNA with endocytic vesicle markers in HeLaLuc cells at 
various times post-transfection with PEI/AF647-siRNA polyplexes.  Eight cells from three 
different images with 10 z-slices were quantified (points = mean colocalization values of 8 cells, 
error bars represent standard deviations).  
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Figure 2.7. Efficiency of HeLaLuc cell disruption by Dounce homogenizer. The efficiency was 
evaluated as the ratio of protein content in PNS to total cellular protein. 
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Figure 2.8. Identification of endosomal markers in iodixanol density gradient fractionation. Inlay 
represents average density of collected fractions. 
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Figure 2.9. Distribution of siRNA delivered to HeLaLuc cells fractionated on iodixanol density 
gradient experiment. Inlay represents average density of collected fractions. 
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Figure 2.10. Density profile of 15 and 20% Percoll gradient. Each point represents average 
density of four collected samples; error bars represent standard deviation. 
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.
Figure 2.11. Identification of endosomal markers in a 15% Percoll gradients experiment. Inlay 
represents corresponding ratio of Rab7/Rab5 signals representing location of LEs. 
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Figure 2.12. Identification of endosomal markers in 20% Percoll fractionation experiment. Inlay 
represents corresponding ratio of Rab7/Rab5 signals representing location of LEs. 
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Figure 2.13. Distribution of lysosomal marker β-hexosaminidase in 20% Percoll gradient from 
four 100 mm HeLaLuc plates. 
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Figure 2.14. Distribution of total protein content in 20% Percoll gradient from four 100 mm 
HeLaLuc plates fractionated on 20% Percoll gradient 
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Figure 2.15. The location of the siRNA delivered to HeLaLuc cells as described in 2.2.3 within 
the top fractions of the 20% Percoll gradient. Only PBS represents siRNA attached to PMs and 
internalized. Includes HS represents only the internalized siRNA. Most of the adsorbed 
polyplexes can be found in the top two fractions of the gradient 
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Figure 2.16. Kinetics of siRNA distribution. HeLaLuc cells were transfected with polyplexes for 
time intervals indicated on the graphs and fractionated on 20% Percoll gradient. The 30-minutes 
graph is the same on both charts for the scale reference. 
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Figure 2.17. Summary of the intracellular trafficking kinetics of PEI/siRNA polyplexes in 
HeLaLuc cells from fractionation experiment on 20% Percoll column. Background fluorescence 
was subtracted from each fraction, and the fluorescence of all fractions 2-45 in each sample was 
summed and used to normalize values in each fraction. Fractions 3-11, 11-17 and 38-42 were 
added to represent EEs, LEs and LYs, respectively. 
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Figure 2.18. Intracellular trafficking of PEI/siRNA polyplexes in HeLaLuc cells. The fluorescence 
that was lost during the crosslinking normalized by the corresponding controls (no H2O2) 
represents fractions of siRNA-AF647 in different compartments. Mean ±range, n=2. 
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Figure 2.19. Dextran was either added simultaneously with HRP-AF647 or 30 minutes after the 
HRP was introduced to prove wither the fluorophore or the concentration of HRP affected DAB-
cytometry experiments. Mean ±range, n=2. 
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Figure 2.20. Effects of the disruption of endocytosis at various stages around the EE 
compartment on the efficiency of RNAi from polyplexes. N = 3 Error bars represent s.d..* - 
p<0.05 compared to Control; # - p<0.05 between the WT and DN types. 
 
F 
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Chapter 3. Elucidation of the role of cholesterol in DOTAP-based siRNA vectors 
3.1 Introduction 
 The first account of delivery of nucleic acids using synthetic cationic lipid was published 
by Felgner et al. in 19871. The researchers used cationic N-[1-(2,3-dioleyloxy)propyl]-N,N,N-
trimethylammonium chloride (DOTMA) that spontaneously formed multilamellar liposomes. 
These liposomes were mixed with DNA to achieve remarkable 100% entrapment of nucleic acids 
as they formed complexes by means of electrostatic interactions. They also hypothesized that the 
charge of the cationic vector gave the particles the ability to come in contact with the anionic PMs. 
Several remarkable observations were reported in that paper: lipoplexes fused with PMs, addition 
of neutral lipid could control the fusogenic process, transfections were not efficient in the presence 
of serum and significant toxicity resulted from the longer transfections. The same group later 
published another report in which RNA was delivered to various cells lines using their newly 
developed lipofection method and envisioned the application of their technology to delivery of 
various antisense RNA molecules2. Since then, numerous lipids were synthesized in an attempt to 
overcome the lipoplex delivery challenges identified by the pioneers of the field1 (control over 
fusion with bio-membranes, serum stability, toxicity) as well as challenges identified later after 
closer look at transfections in vitro (endosomal escape3, recycling4, endocytic pathway specificity5, 
autophagy6) and in vivo (targeted delivery7, biodistribution8).  
 The lipids that are commonly employed for gene delivery consist of three basic parts: head-
group, linker and hydrophobic tail. Cationic lipids are thought to form liposomes of lamellar (Lα), 
micelle or inverted hexagonal phase structures (HII). These structures can be predicted using a 
packing parameter that relates hydrophobic tail volume to hydrophilic headgroup area times the 
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length of the hydrophobic tail9,10. When these structures are mixed with nucleic acids, they most 
often form lipoplexes with structural phases corresponding to their predecessor liposomes11.  
Even though lipids have a long history as gene delivery vectors, there are still competing 
hypotheses that attempt to explain their interactions with biological membranes. Systematic but 
empirical chemical modification of lipids for nucleic acids delivery is commonly performed in 
order to understand the correlation between the vector properties and transfection efficiencies. 
However, due to the intricacy of the endocytosis (the first step in transfection) is a multi-stage 
process during which the internalized particles experience a wide range of interactions (e.g. 
interactions with receptors, phospholipids, glycoproteins) under different environmental 
conditions (e.g. pH, reducing environment) at these stages, it is exceedingly difficult to understand 
the correlations between the chemical structure of the lipoplexes and the transfection efficiencies11. 
In general, the only consensus easily observed in the literature regarding such correlations relates 
to the increase in transfection efficiencies observed with lipoplexes that change their 
supramolecular structure upon interaction with biological membranes12. Upon structural inversion, 
destabilization of endosomal membrane occurs resulting in cytosolic release of delivered 
molecules13. However, the association between the structures of lipid/nucleic acid complexes and 
transfection efficiencies is missing and can only be established by close examination of 
interactions of lipoplexes with biological membranes11.  
Strong evidence indicates that when the polyplexes are in the HII state, the charge density 
of the particles does not affect the transfection efficiencies. In contrast, the relationship between 
the transfection efficiency vs. the charge density of Lα-lipoplexes can be described by a bell-shaped 
curve14. Increasing the charge is attributed to promotion of endosomal escape, but increasing the 
charge over certain value might hinder the separation of nucleic acids from the lipids and reduce 
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the transfection efficiencies15. When the liposomal-based delivery of siRNA was compared to 
DNA, it was revealed that much higher cationic charge densities of lipids are required to achieve 
siRNA delivery compared to DNA delivery16. The requirement for the use of higher charge 
densities for siRNA transfections can be satisfied by the use of large amounts of monovalent lipids 
or the use of polyvalent lipids. However, these are known to cause cytotoxicity16–18. Therefore, 
great efforts have been made to investigate the potential of ionizable cationic lipids19, mixtures of 
cationic lipid-like materials20, and more simple inclusion of neutrally charged or zwitterionic 
“helper lipids” such as cholesterol or 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine 
(DOPE)21–23. 
  Cholesterol is commonly included as part of lipoplex formulations as it is assumed to 
increase “stability” of the particles13. In siRNA-delivery studies, inclusion of cholesterol is often 
described as a means to “improve serum stability”24,25. Yet, it has been shown that incorporation 
of cholesterol into DOTAP liposomes increases the ability of this vector to deliver DNA in vitro 
at high concentrations of serum in media without having a noticeable effect on the interaction 
between the particles and the media26. Incorporating cholesterol above certain concentrations can 
create cholesterol-rich domains on vectors that might facilitate direct fusion of vectors with PM 
and other internal membranes and promote DNA delivery efficiency27–29. Cholesterol might also 
assist in displacing the water molecules at the boundary layer of the lipoplexes. This will result in 
lowering of the energy barrier for particles to come in contact with biological membranes14,30,31. 
Whatever the case might be, it is imperative to study the effects of the inclusion of cholesterol in 
lipoplexes in relationship to as many endocytic steps as possible in order to truly understand its 
function. Accordingly, this chapter presents a study of the effects of cholesterol inclusion in 
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cationic lipid vectors on transfection efficiencies and intracellular processing of siRNA lipoplexes 
using the comprehensive methods that were described in Chapter 2.   
3.2 Materials and Methods 
3.2.1 Cells, Nucleic Acids and Vectors 
HeLaLuc (luciferase-expressing cervical cancer) cells were a kind gift from Mark Davis 
group at Caltech. The culture media, culture conditions and oligonucleotides were the same as 
described in 2.2.1.  
 Branched 25 kDa PEI was used as described in 2.2.2. DOTAP and cholesterol were 
obtained from Avanti (Alabaster, AL). The lipids were first dissolved in chloroform at a 
concentration of 10 mg/ml, mixed at ratios of 0:1, 0.1:1, 0.3:1 and 0.6:1 cholesterol:DOTAP 
(w:w) in glass tubes and placed overnight in a vacuum chamber. On the next day, the lipid layers 
that formed on the bottom of the glass tubes were suspended in PIPES buffer (20mM PIPES, 
150mM NaCl in water) to a final concentration of DOTAP of 0.2 mg/ml using water-bath 
sonicator. The lipid solutions were then extruded through a 100-nm polycarbonate membrane 11 
times using Mini-Extruder setup (Avanti). Following the extrusion, the lipid stock was placed in 
the refrigerator and used in experiments on the same day. 
3.2.2 Formation of Polyplexes and Lipoplexes and Transfections 
 Polyplexes were formed at room temperature in PIPES buffer by mixing 20 µM stock 
siRNA solution with 1 mg/ml PEI solution to give a final weight ratio of 10:1 (PEI:siRNA) as 
described in 2.2.3. Similarly, siRNA was mixed with the solutions of extruded lipids in PIPES 
buffer to yield final weight ratios of 10:1 (DOTAP:siRNA). The amount of DOTAP and siRNA 
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in each group was the same, but the amount of cholesterol was varied. Both types of particles were 
incubated at room temperature for 20 min before the transfections. 
 To estimate the transfection efficiency of the formed particles, HeLaLuc cells were 
transfected in serum-free DMEM media for 4 h with 5 nM siRNA as described in 2.2.3. Six wells 
were used for each vector; three wells for siGL3 and three wells for siNeg groups of each vector. 
The cells were incubated for 20 hours after the transfections, lysed with cell culture lysing reagent 
(CCLR), and the luciferase expression from each sample was normalized to the total protein 
content measured by BCA assay. The reported knockdown for each vector was calculated as 1- 
𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝐿𝑢𝑐 𝑠𝑖𝐺𝐿3
𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝐿𝑢𝑐 𝑠𝑖𝑁𝑒𝑔
. 
3.2.3 Uptake Measurements 
 Flow cytometry was used to assess the uptake of fluorescent siRNA particles. HeLaLuc 
cells at a concentration of 3x105 cells/well were seeded 24 hours before the transfections. Particles 
were formed with AF647-tagged siRNA as described in 3.2.4, the media was changed to the serum-
free media, and transfections were carried out with the final siRNA concentration of 5 nM in each 
well for 2 h. The wells were washed once with 0.001% SDS solution in PBS following additional 
wash with PBS. The cells were then trypsinized with 200 µl of 0.25% trypsin in PBS solution and 
collected in separate tubes, and 300 µl of FBS was added to each sample to neutralize trypsin. The 
subsequent steps were performed on ice. Flow cytometry was done on BD FACSCanto flow 
cytometer (BD Biosciences, San Jose, CA) and analyzed using FCS Express v.3.0 software (De 
No Software, Los Angeles, CA). The gate was set to measure only live cells based on the forward 
and side scattering, and at least 10,000 cells were collected in each group.  
79 
 
The internalization and the binding to PMs of the fluorescently-labeled siRNA particles 
were measured as described in 2.2.4. siRNA particles were formed 20 minutes prior the 
transfections, and six wells were transfected for each vector. The transfections lasted different time 
periods up to 180 minutes, and three of the wells from each group were washed twice with cold 
PBS while the other three wells were washed once with ice-cold solution of 100 IU/ml of heparin 
in PBS followed by a plain PBS wash. The cells were then lysed with 200 µl of lysing solution (1% 
Triton X-100, 2% SDS in PBS). The fluorescence of the lysate was compared to a standard curve 
to determine the molarity of siRNA in cells and normalized by total protein content in each sample. 
The uptake values are reported in units of nmol/µg denoting the amount of internalized siRNA per 
the weight of the total detected protein in each sample.  
3.2.4 Sedimentation fractionation 
 Intracellular trafficking kinetics were investigated using fractionation method on 20% 
Percoll gradient as described in 2.2.7. The cells were transfected with lipoplexes at final siRNA 
concentration of 5 nM in 100-mm culture dishes for different time intervals. The control sample 
for each experiment was a plate with cells that were not transfected. After the fractionation 
procedure, the fluorescence of the collected fractions was corrected by the background 
fluorescence from the corresponding fractions from the control sample. The fluorescence from 
fractions determined earlier as representative of EEs, LEs and LYs (Fig. 2.17) were summed and 
normalized by the summed fluorescence of fractions 2-24 of the corresponding gradients to present 
the kinetics of siRNA delivered by lipids in three intracellular compartments. The density of each 
of the collected fraction was also measured as described in 2.2.7. 
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3.2.5 DAB-cytometry 
 The intracellular trafficking kinetics of the fluorescently-labeled lipoplexes were evaluated 
using a newly designed protocol described in 2.2.8. LYs were preloaded with a 30-minutes pulse 
of 1 mg/ml of HRP with a 90 minutes chase after which lipoplexes were introduced to cells for 
different time intervals. The entire endolysosomal pathway was also loaded with HRP for 2 hours 
before the lipoplexes were introduced, and HRP remained in the media during the transfections. 
EEs were marked with HRP only during the last 5 minutes of the transfections. Further processing 
was performed as described in 2.2.8, and the reported values (insoluble fractions) represent 
fractions of internalized siRNA within different compartments of the total internalized detected 
siRNA. 
3.2.6 Particle characterization 
 Polymer and lipid-based siRNA particles were prepared at a weight ratio of 10:1 
(vector:siRNA) in PIPES buffer as described in 3.2.4. Dynamic light scattering (DLS) using 
Brookhaven Instruments Corporation 90 Plus Particle Size Analyzer (Holtsville, NY) was 
performed to characterize the size and the polydispersity of the particles. The formed particles 
were added to transparent cuvettes filled with 2 ml of DMEM to final siRNA concentration of 15 
nM. In one group, the solutions with particles were added to DMEM just prior to the measurements; 
in another group, the filled cuvettes were placed in a 37 °C incubator for 4 hours before being 
analyzed to investigate their potential aggregation. Extruded lipids without added siRNA were also 
investigated. Each sample was scanned 10 times, and the average of three samples is reported. 
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3.3 Results 
3.3.1 RNAi knockdown 
 siRNA targeting the luciferase (Luc) reporter gene and non-targeting siRNA were 
delivered to cells using PEI and a set of DOTAP-based vectors to evaluate their efficiency. Very 
modest knockdown of ~30% was achieved with 5 nM siRNA delivered by PEI. Results of earlier 
studies performed in our lab are consistent with the data presented in this report. They 
demonstrated that at the range of transfection conditions used here, the values of Luc knockdown 
in these cells are very sensitive to both the amount of delivered siRNA and the PEI/siRNA ratio32. 
The transfection conditions were chosen to ensure that the observed effects are not associated with 
saturation of RNAi machinery or major interference with cellular biology of the investigated 
system. The downregulation of the reporter gene was measured ~20 hours after the delivery and 
was comparable between the polyplexes and 0:1 and 0.1:1 (w:w) cholesterol:DOTAP lipoplexes. 
Increase in cholesterol content in the particles to 0.3:1 (w:w) prompted greater RNAi activity that 
leveled off as the cholesterol content reached 0.6:1 (w:w) (Fig. 3.1). 
3.3.2 Uptake kinetics 
 Flow cytometry was used to investigate the ability of different vectors to facilitate the 
siRNA uptake. The transfections lasted 2 hours before the cells were collected for FACS (Fig. 3.2). 
On average, polyplexes had much higher uptake than lipoplexes with lower cholesterol. Increase 
in cholesterol content of lipoplexes increased the uptake. The average fluorescence of siRNA 
delivered by PEI was just slightly below the fluorescence from siRNA delivered by 0.6:1 vector. 
However, the range of uptake values was much broader in the case of PEI compared to lipoplexes, 
so the median fluorescence of PEI-delivered siRNA was in the range between the fluorescence 
from 0.1:1 and 0.3:1 (w:w) cholesterol:DOTAP particles. 
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Another highly sensitive method (3.2.3)33 was used to evaluate the kinetics of the particles 
uptake and their total association with PMs. During the 3 hours of transfection the total detected 
internalization of 4.48x10-6±1.39X10-7, 5.31X10-7±8.13X10-8, 2.10X10-6±1.40X10-7, 2.74X10-
6±2.64X10-7, 4.36X10-6±4.98X10-7 nmol siRNA/µg  protein by PEI, 0:1, 0.1:1, 0.3:1 and 0.6:1 
cholesterol:DOTAP liposomes, respectively, was observed (Fig. 3.3-3.7). The trend confirmed the 
uptake measured by FACS. At 3 hours post-transfection, 60-80% of lipoplexes associated with 
cells were internalized (Fig. 3.8) as opposed to only 20% internalized polyplexes (Fig. 3.9). The 
experimental errors were higher when the uptake of lipoplexes was investigated compared to 
polyplexes because of the lower uptake (lower signal to noise ratio). 
 3.3.3 Intracellular kinetics: Percoll fractionation 
 The intracellular distribution of lipoplexes as a function of transfection duration was 
estimated by subcellular fractionation on 20% Percoll gradient as was previously performed for 
polyplexes (2.2.7). As with the measurements of total uptake, the lipoplexes with lower cholesterol 
amounts delivered less siRNA (Figs. 3.10-3.11) than vectors with higher cholesterol content (Figs. 
3.12-3.13) or PEI (Fig. 2.16). This resulted in a lower signal to noise ratio and lower detection 
capabilities. The density of the collected fractions verified the consistency between the 
fractionation experiments (between 1.044 and 1.061 g/ml) (Fig. 3.14). The density range was 
slightly broader in previous experiments with PEI (1.039 to 1.067 g/ml, Fig. 2.10). Still, the 
discrepancy between the previous experiments and the experiments presented here is mainly at the 
non-linear “edges” of the gradients. For example, in lipoplexes, fraction 33 had density of 1.050 
g/ml while in the experiments with polyplexes average density of 1.050 g/ml corresponded to 
fraction 30. Considering the fact that the fractions were manually collected and the sedimentation 
83 
 
nature of the separation (as opposed to isopycnic), the density profiles justified the ranges of 
representative fractions described in 2.3.4 (EEs, fractions 3-11; LEs, 11-17; LYs, 38-42) . 
 The summary of the fractionation experiments is presented in Fig. 3.15. Based on these 
experiments, the lipoplexes delivered little siRNA to LYs. None of the lipids delivered more than 
15% of internalized particles to LYs during the 2 hours of transfections. 0:1 cholesterol:DOTAP 
vector showed the highest delivery to LEs peaking at 15 minutes at ~23% and then gradually 
reducing to 15% in that compartment. The siRNA detected in EEs between 30 and 120 minutes 
did not vary after 15 min post-transfection for all samples and averaged 27±1.6, 34±1.8, 38±2.1, 
51±2.9% for 0:1, 0.1:1, 0.3:1 and 0.6:1 cholesterol:DOTAP vectors, respectively. However, the 
top EE fractions likely contained substantial amounts of siRNA from cytosol and broken 
organelles as discussed earlier (2.4).  
3.3.4 Intracellular kinetics: DAB cytometry 
 The DAB cytometry method that was developed in 2.2.8 was used to investigate the 
intracellular trafficking of internalized siRNA lipoplexes (Figs. 3.16-3.19). The amount of siRNA 
observed in the entire endolysosomal system (total insoluble fraction) decreased with increasing 
cholesterol content in the lipoplexes. The fraction of siRNA eliminated by crosslinking of the total 
endocytic system quickly increased for all cholesterol-containing vectors during the first 30 
minutes and then continued to grow very slowly for the remainder of the transfections. This was 
in contrast to the DOTAP-only vector which at the first measured time point (5 minutes) delivered 
the majority of siRNA (53±12.6%) to endocytic vesicles and kept ~60-70% of total siRNA within 
endocytic vesicles for the 3-h duration of the transfection. Surprisingly, nearly no siRNA was 
delivered by the 0:1 cholesterol:DOTAP liposomes to the EEs in the first 15 minutes, and the 
percentage of siRNA in EEs was stagnant at ~25% between 60 and 180 minutes. This could be a 
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result of either different endocytosis pathways taken by DOTAP and HRP that have different 
internalization rates or the detection limit of such small amounts of siRNA/DOTAP-only particles 
that entered cells in the first 5 minutes. At 3 hours post-transfection, 63±3.0, 55±12.6, 44±0.3 and 
46±2.1% of siRNA delivered by 0:1, 0.1:1, 0.3:1 and 0.6:1 cholesterol:DOTAP vectors, 
respectively, were detected in all endolysosomal vesicles containing HRP.  At 3 hours post-
transfection, 23±5.0, 27±10.1, 23±1.7 and 9±2.4% of total siRNA delivered by 0:1, 0.1:1, 0.3:1 
and 0.6:1 cholesterol:DOTAP vectors, respectively, were located in EEs. Hence, an increase in 
cholesterol in lipoplexes reduced the retention of the particles within the EEs. This could also be 
corroborated with the reduction in the transport of lipoplexes into LYs, which was lower in the 
0.6:1 and 0.3:1 compared to 0.1:1 and 0:1 cholesterol:DOTAP liposomes.  
3.3.5 Physical characteristics of particles 
 Polyplexes and lipoplexes were analyzed for their size (Fig. 3.20) and polydispersity (Fig. 
3.21) by DLS. The polyplexes formed with siRNA were on average 212 nm in diameter, which 
increased by approximately 50 nm during 4 hours of incubation at 37 ºC in transfection media. 
The size of liposomes (~190-210 nm) was nearly independent of their composition after the 
extrusion. Each sample of liposomes approximately doubled while incubated for 4 hours without 
siRNA. The composition of the lipids appeared to have no influence on the initial size of the 
particles or their size stability. Polyplexes grew by 18% of their original size during the 4 hours of 
incubation, while 0:1, 0.1:1, 0.3:1 and 0.6:1cholesterol:DOTAP lipoplexes grew by 93%, 86%, 
134% and 181% of their original size, respectively. At the same time, the polydispersity of the 
liposomes greatly increased during the 4 hours of incubation for all formulations except 0.6:1 
cholesterol:DOTAP vectors, while the polydispersity of assembled lipoplexes increased to a large 
extent only for the 0.3:1 cholesterol:DOTAP vectors. The polydispersity of polyplexes 
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immeidately after the formation and after the 4 hours of incubation was high and comparable to 
the polydispersity of lipoplexes of higher cholesterol content after 4 hours of incubation. 
3.4 Discussion 
 Despite the advancement in the knowledge of the biology of endocytosis, the interactions 
between the internalized particles and endocytic membranes are difficult to explain or predict. 
Such predictions should serve as a basis for the design of vectors for nucleic acids delivery34. 
Currently, an empirical approach is most often used in optimization of synthetic delivery vectors35. 
As was noted in a report that described gene delivery by cationic lipids, the majority of the studies 
that investigated biophysical processes involved in drug delivery using particles concentrated on 
the uptake mechanisms and ultimate destination of the particles and “neglected intracellular 
trafficking” involved in the process36. This might be largely the case because of the lack of reliable 
and simple methods to investigate the intracellular trafficking. The principal aim of this study was 
to relate RNAi efficiency, uptake and intracellular trafficking with the chemical composition of 
the delivery vectors through methods developed in the preceding chapter. 
 Cholesterol is frequently used in the formulations of cationic liposomes as a promoter of 
transfection efficiencies, but its function is vague37. The inclusion of cholesterol is often motivated 
by increased stability in a form of resistance to shear stress that it provides to lipoplexes13 or as 
means to reduce aggregation of particles that occurs in the presence of serum24,25. Regardless, 
increasing cholesterol content in the presented experiments promoted knockdown in in vitro 
serum-free conditions (Fig. 3.1). This was in line with the observations by flow cytometry of 
increased internalization of siRNA as the amount of cholesterol in vectors increased (Fig. 3.2). 
Pozzi et al. reported that the inclusion of cholesterol into DOTAP-based vectors activates uptake 
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of these particles by caveolin and clathrin-mediated endocytosis in addition to macropinocytosis 
that was the only observed active internalization route of DOTAP particles in CHO cells37. This 
could well explain the increase in uptake and knockdown seen for vectors with higher cholesterol 
content, but further investigation revealed that increase in cholesterol also increased the amount of 
siRNA that attached to PMs during the transfections (Figs. 3.3-3.6). At least two distinct physical 
properties of particles can govern their ability to reach PMs in vitro: hydrodynamic diameter and 
charge. The sedimentation rate of particles increases with the square of their diameter, and 
adsorption of polyplexes and lipoplexes to large particles was shown to improve transfection 
efficiency by increasing the local concentration of the delivered cargoes next to PMs38. Still, the 
range of sizes of the lipoplexes is not sufficient to support sedimentation rate as a factor in the 
reported phenomenon (Fig. 3.20).   
Proteoglycans are mostly anionic molecules located on PMs. Proteoglycans are responsible 
for initial attraction between the PMs and cationic particles which can be the limiting step to 
internalization and transfection efficiency39. ζ-potential is an important indicator of the 
electrostatic attraction between the particles and PMs. Son et al. suggested to use ζ-potential of 
particles as the main prediction factor of their success in in vitro studies40. Measurements of the ζ-
potential of polyplexes and lipoplexes in transfection media were attempted in this study, but the 
results were inconsistent and are not reported here. However, published reports strongly indicate 
that the inclusion of cholesterol in DOTAP particles (both liposomes and formed lipoplexes) does 
not significantly alter their ζ-potential21,27,28. The commonly used36,40 method of estimation of this 
potential (Smoluchowski relation) might be applicable to liposomes only in a very narrow range 
of physical properties of the particles41. ζ-potential describes the charge at a plane between the 
fixed and diffuse ion layer, but this plane is located away from the plane of amino groups of lipids 
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that interact with biological membranes21. Therefore, ζ-potential, if estimated correctly, can 
provide insight into long-distance interaction between particles and PMs, but it cannot explain or 
predict the processes once particles reach PMs and is not a feasible explanation to the clear 
correlation between the cholesterol content in vectors and the detected siRNA on PMs.  
The inclusion of cholesterol effectively diluted the charge (lowered the charge density) 
provided by DOTAP on the particle’s surface. Therefore, the charge density on the surface of the 
lipid particles was reduced as the amount of cholesterol increased. The inclusion of cholesterol in 
DOTAP liposomes was shown to greatly enhance the “dryness” of the resultant particles31. Polar 
head groups of lipids attract water molecules which form a hydration layer. Before lipid 
membranes can come into contact, they have to overcome hydration repulsion created by steric 
interactions of the water molecules surrounding the lipids. The repulsion arises at distances of 1 to 
3 nm between the approaching lipids and exponentially increases until the dehydration of the 
approaching surfaces occurs10,14. The ability of cholesterol to dehydrate lipid membranes was 
implicated in the remarkable boost of transfection efficiency of DOTAP-based DNA particles30. 
Zidovska et al. concluded that endosomal escape of DNA particles was enhanced by cholesterol-
driven dehydration, and addition of 15 mol% cholesterol to vectors increased transfection 
efficiencies by 10 fold30. But the authors did not investigate the overall uptake of the particles and 
did not base their conclusions of endosomal escape on direct experimental evidence. Here, the 
presented data indicates that the overall uptake is also influenced by the lipid hydration. The initial 
attachment of lipoplexes to PMs was estimated as a difference between the detected particles after 
a light PBS-wash and the internalized particles detected following the wash with HS. Therefore, it 
is conceivable that the dehydration provided by cholesterol promoted attachment of particles on 
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PMs independently from its potential influence of the sedimentation rates or ζ-potential of the 
particles.  
The two essential steps involved in all endocytosis pathways include membrane 
invagination and detachment from PMs which creates new vesicles42. A theoretical framework 
was established to explain the interactions between the lipid membranes and the adsorbed 
particles43. As particles come in contact with fluid lipid membranes, the adhesion forces induce 
elastic deformation in the membranes. Given certain properties of fluid membranes (surface 
tension) and particle-membrane interactions, “sufficiently large particles will always at least 
partially wrap” lipid membranes43. Moreover, larger particles that strongly interact with 
membranes can undergo “passive endocytosis44”. This means that internalization of particles can 
happen even without active endocytosis protein machinery. This was demonstrated by introduction 
of silica particles to red blood cells that lack active endocytosis function. The smaller silica 
particles (~100 nm) simply adsorbed on red blood cells, but the larger particles (~600 nm) 
spontaneously internalized. The authors explained that larger particles release more energy when 
adhered to PMs compared to smaller particles45. In addition, the internalization of larger particles 
requires less energy to deform PMs compared to smaller particles45. Since these particle-membrane 
interactions are capable of driving internalization even without the active endocytosis, they likely 
have a significant impact on the active endocytosis. An earlier study identified a strong positive 
correlation between the size of the DOTAP-based lipoplexes and their transfection efficiency. The 
discussion explained that the size of the particles is more detrimental to the delivery efficiency 
compared to the ζ-potential, stability properties or even the specific structure of the lipoplexes46. 
The inclusion of cholesterol in vectors could not only improve overall adhesion of particles to PMs 
but also promote endocytosis, since the cholesterol-rich liposomes complexed into larger particles 
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compared to liposomes with small cholesterol content (Fig. 3.20). Thus, the increase in initial 
attachment and internalization of siRNA mediated by cholesterol can be explained through the 
framework of fundamental particle-fluid membranes interactions43,44.   
As discussed in the previous chapter, one of the main hurdles in using cell fractionation 
technique involves inability to distinguish between cytoplasmic siRNA and siRNA released as a 
result of mechanical damage to organelles. The fractions that were previously determined as 
enriched in EEs contained more siRNA as the amount of cholesterol in lipoplexes increased (Fig. 
3.15). Yet, a nearly opposite correlation can be observed with LE-fractions. The more precise 
DAB-cytometry method revealed that the trafficking of lipoplexes cannot be elucidated with 
subcellular fractionation techniques, since even bigger fractions of internalized lipoplexes avoid 
confinement of endosomes compared to polyplexes (Figs. 3.16-3.19 vs. Fig. 2.18).  In addition, 
very small fraction of lipoplexes could be located within EEs compared to polyplexes. This 
highlights the need for precise methodology required to investigate intracellular trafficking. Since 
polyplexes were more often trapped inside endocytic vesicles compared to lipoplexes, more 
information regarding endocytosis steps could be extracted from the subcellular fractionation 
studies for polyplexes compared to lipoplexes.   
Both the lumen and the membranes of EEs are mainly composed of fused primary 
endocytic vesicles47. These vesicles are formed from detached sections of PMs. This means that 
there is a great overlap between the interactions observed between PMs and particles and between 
EEs membranes and particles. However, when particles arrive onto PMs their effective area of 
interaction is smaller compared to the stage after the internalization. Another difference is in the 
activity of hydrogen ions that rapidly increases as the particles internalize (pH 7.4 on PMs to pH 
6.2 in EEs)42. These aspects might explain the results of the presented experiments. The increase 
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in cholesterol content of lipoplexes not only enhanced the interactions between the lipoplexes and 
PMs that led to enhanced uptake, but also enhanced the endosomal-escape properties of the 
particles as observed by the increase in the cytosolic fraction of the delivered siRNA. 
DOTAP is a quaternary ammonium derivative; therefore, its cationic charge is not 
changing as a result of the pH environment, and it is not expected that DOTAP-based lipoplexes 
will respond to acidic environment of endosomes48. At later stages of transfections (> 120 minutes) 
smaller fractions of siRNA in EEs corresponded to vectors with increased cholesterol amounts. 
This implies that either the increase of cholesterol caused more siRNA to escape EEs or it 
somehow promoted faster maturation of EEs. Just like in the case of the PMs-particles interactions, 
the dehydration effect provided by cholesterol allowed for reduction of steric forces required to be 
overcome before lipoplexes came into direct contact with endosomal membranes. Strong evidence 
indicates that the inclusion of cholesterol in liposomes greatly promotes the ability of vectors to 
adopt inverted hexagonal phase when they come in contact with anionic phospholipids located 
within endosomal membranes 49. Hafez et al. showed that a 90-nm liposome composed of 50 mol% 
cationic lipids can completely disrupt the bilayer structure of a typical 200-nm endosome49. Since 
the increase in size of the assembled lipoplexes as a result of cholesterol addition was more 
pronounced compared to the size increase of liposomes (Fig. 3.20), it is probable that more cationic 
lipids entered endosomes with cholesterol-rich particles. These, in turn, had higher potential to 
cause transition from bilayer to inverted hexagonal structures and release their cargo to cytosol.  
The fractions of siRNA in LYs determined by DAB-cytometry revealed an interesting 
pattern in which cholesterol assisted in escape from the endocytic vesicles. With no-cholesterol 
lipoplexes, over 91% of siRNA located within the total insoluble fraction can be accounted for by 
the siRNA detected in the LYs fraction at 180 minutes time point. These values are 74, 67 and 71% 
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corresponding to 0.1:1, 0.3:1 and 0.6:1 cholesterol:DOTAP lipoplexes, respectively (Figs. 3.16-
3.19). Thus, cholesterol content ratio higher than 0.1:1 did not contribute to escape from later 
endocytic vesicles that ultimately delivered cargo to LYs. The overall fraction of siRNA in LYs at 
180 minutes was inversely proportional to cholesterol content in vectors. Still, it might be 
surprising that at such small fractions of siRNA in EEs, the growth of lysosomal fraction of siRNA 
delivered by 0.6:1 cholesterol:DOTAP vector was nearly constant. This could be due to an 
autophagy process that was recently implicated in re-capturing of over 75% of PEI/DNA particles 
injected directly into cytosol  and ultimately delivering them to LYs in HeLa cells6. The relatively 
slow rate6 of the process makes this explanation unlikely, but since the total insoluble fraction of 
0.6:1 cholesterol:DOTAP lipoplexes slowly increased between 60 and 180 minutes while the 
fraction of siRNA in EEs remained low and constant, the possibility of some autophagy response 
cannot be excluded.  
It is of great interest to compare the uptake and the intracellular trafficking kinetics of 
polyplexes and lipoplexes. Even though the average amount of internalized siRNA delivered by 
PEI is comparable to the siRNA delivered by 0.6:1 cholesterol:DOTAP liposomes, flow cytometry 
demonstrated that the median uptake values are much more aligned with the internalization using 
0.1:1 cholesterol:DOTAP liposomes (Fig. 3.2). This might be related to the higher polydispersity 
of the PEI-based particles compared to lipoplexes (Fig. 3.21). For all of the lipoplexes, the fraction 
of the particles detected on PMs was no larger than 70% at the early transfection time points and 
no larger than 40% at the later times (Fig. 3.8). These values correspond to 95% and 80% in the 
case of PEI (Fig. 3.9). Overall, this indicates that the polymer was not as effective at overcoming 
the delivery barrier related to initial internalization compared to lipid vectors. Given the geometric 
heterogeneity of the polyplexes, the difference between the average and the median polyplex 
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uptake and the long effective residence time that polyplexes spent on PMs, it is tempting to 
speculate on whether the polyplexes of only specific size range delivered siRNA. As discussed 
above, larger particles have generally lower energy barrier of internalization. Earlier PEI-based 
DNA delivery study reported an accumulation of polyplexes into large “clumps” on PMs prior to 
their internalization50. Similar aggregations on PMs via cytoskeleton-directed movement of DNA 
lipoplexes were reported to possibly promote or even initiate endocytosis51. This could also be a 
factor in the siRNA delivery, and even though the average size of polyplexes in PIPES buffer is 
smaller than that of any of the studied lipoplexes (Fig. 3.20), they might clump into larger 
aggregates on PMs before the initial uptake step. The relationship between the size of the 
internalized particles/aggregates and their intracellular fate is difficult to investigate due to 
challenges in size estimations of the constructs in physiological environments.  
The dynamics of the total insoluble fraction of cholesterol-free lipoplexes (Fig. 3.16) was 
very similar to the one observed with PEI-based particles (Fig. 2.18). Still, more siRNA could be 
located outside of the entire HRP-marked endocytic pathway delivered with DOTAP vector 
compared to PEI vector during the transfections. The fraction of these lipoplexes in LYs increased 
in a nearly linear manner compared to the polyplexes that, after a rapid rise to ~20% within the 
first 30 minutes, remained steady for 90 minutes and increased again to 36% in the last half an 
hour. Given the data on the polydispersity of polyplexes, it is feasible to conceive that certain 
polyplexes traveled rapidly through the endocytic vesicles and reached LYs within 30 minutes, 
while others moved more slowly and reached LYs at later times. The possibility of several different 
endocytosis internalization pathways with different internalization rates with common ultimate 
destination in LYs could also explain this observation52. The experimental results presented in this 
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chapter demonstrate qualitative difference in uptake and processing related to composition of 
cationic vectors, and they will be more thoroughly quantified in the proceeding chapters. 
3.5 Conclusion 
 Some interesting insights regarding the role of cholesterol in siRNA delivery by lipoplexes 
were revealed. The inclusion of cholesterol in lipoplexes promoted their initial interaction with 
PMs and subsequent internalization. This was likely achieved by the dehydration effect at the 
particles-PMs interface. As the lipoplexes internalized, it is anticipated that cholesterol contributed 
to their escape to cytosol through both the dehydration effect and the structural destabilization 
effect of the endosomes. An addition of 10 wt% cholesterol to DOTAP assisted in escape to cytosol 
from vesicles downstream of EEs, but additions over that value did not increase this effect. The 
accumulation of siRNA in LYs could not be avoided by addition of cholesterol in instances when 
siRNA did not escape from early endocytic vesicles. The average uptake of lipoplexes increased 
with the increase of cholesterol in the liposomes, and higher uptake correlated with higher reporter 
gene knockdown. 
 Compared to PEI, lipoplexes appeared to travel faster to LYs but have higher chances for 
endosomal escape. High polydispersity of polyplexes could be the main contributor to the wide 
range of siRNA-uptake values on a per-cell basis. However, more investigations should be 
performed relating the physical properties of particles with their endocytosis performance. It is not 
clear if the size and charge of the particles (and their clusters) undergoing endocytosis is well 
correlated with the measurements of these parameters performed before particles began interacting 
with cells. 
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 Several competing explanations regarding the observed relationships between 
physicochemical properties of particles and their intracellular kinetics were provided in this 
chapter. A more definitive perspective will emerge as two more crucial steps describing the 
recycling and the endosomal escape processes will be explored in the next chapter. Finally, the 
investigation will conclude with the mathematical models of transfections by different vectors that 
will incorporate the experimental data obtained in this study. 
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3.7 Figures 
 
Figure 3.1. RNAi activity of polyplexes and lipoplexes in HeLaLuc cells measured by 
knockdown of the Luc gene normalized by protein content and non-specific effects by negative 
control siRNA. 5 nM siRNA was used in all groups with 10:1 (w:w) ratio of PEI and DOTAP to 
siRNA (n = 3, error bars denote s.d.). 
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Figure 3.2. Uptake studies of poly- and lipoplexes in HeLaLuc cells measured by flow cytometry 
two hours after the delivery. The uptake of siRNA increased with cholesterol content increase in 
lipoplexes; the average siRNA delivery using PEI was comparable to the average uptake by 0.6:1 
Chol:DOTAP vector, but the median of uptake in case of PEI was much lower. 
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Figure 3.3. siRNA associated with and internalized by HeLaLuc cells as a function of time post-
transfection with 0:1 cholesterol:DOTAP liposomes.  n = 3, error bars denote s.d.  
 
Figure 3.4. siRNA associated with and internalized by HeLaLuc cells as a function of time post-
transfection with liposomes.  n = 3, error bars denote s.d. 
102 
 
 
Figure 3.5. siRNA associated with and internalized by HeLaLuc cells as a function of time post-
transfection with liposomes.  n = 3, error bars denote s.d. 
 
Figure 3.6. siRNA associated with and internalized by HeLaLuc cells as a function of time post-
transfection with liposomes.  n = 3, error bars denote s.d. 
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Figure 3.7. siRNA associated with and internalized by HeLaLuc cells as a function of time post-
transfection with PEI/siRNA polyplexes.  n = 3, error bars denote s.d. 
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Figure 3.8. The average values of internalized lipoplexes divided by the average values of total 
associated (internalized and loosly bound) particles in HeLaLuc cells as a function of time post-
transfection. 
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Figure 3.9. The average values of internalized polyplexes divided by the average values of total 
associated (internalized and loosly bound) particles in HeLaLuc cells as a function of time post-
transfection. 
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Figure 3.10. Subcellular fractionation (20% Percoll gradient) of 0:1 cholesterol:DOTAP/siRNA 
lipoplexes as a function of time post-transfection. The 30-minutes graph is the same on both 
charts for the scale reference. 
 
107 
 
 
Figure 3.11. Subcellular fractionation (20% Percoll gradient) of 0.1:1 
cholesterol:DOTAP/siRNA lipoplexes as a function of time post-transfection. The 30-minutes 
graph is the same on both charts for the scale reference. 
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Figure 3.12. Subcellular fractionation (20% Percoll gradient) of 0.3:1 
cholesterol:DOTAP/siRNA lipoplexes as a function of time post-transfection. The 30-minutes 
graph is the same on both charts for the scale reference. 
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Figure 3.13. Subcellular fractionation (20% Percoll gradient) of 0.6:1 
cholesterol:DOTAP/siRNA lipoplexes as a function of time post-transfection. The 30-minutes 
graph is the same on both charts for the scale reference. 
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Figure 3.14. Densities of the collected fractions from the 20% Percoll fractionations with delivered 
lipoplexes were confirmed using method described in 2.2.7. 
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Figure 3.15. Summary of the intracellular trafficking kinetics of lipoplexes from subcellular 
fractionation experiments on 20% Percoll column. Background fluorescence was subtracted from 
each fraction, and the fluorescence of all fractions 2-45 in each sample was summed and used to 
normalize values in each fraction. As described in 2.3.4, siRNA content in fractions 3-11, 11-17 
and 38-42 were summed to represent EEs, LEs and LYs, respectively. 
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Figure 3.16. DAB-cytometry of 0:1 cholesterol:DOTAP/siRNA lipoplexes delivered to HeLaLuc 
cells as a function of time post-transfection. “Insoluble fraction” indicates the fluorescence that 
was lost during the crosslinking normalized by the corresponding controls (no H2O2). Mean ±s.d., 
n=2.  
 
113 
 
 
Figure 3.17. DAB-cytometry of 0.1:1 cholesterol:DOTAP/siRNA lipoplexes delivered to 
HeLaLuc cells as a function of time post-transfection. “Insoluble fraction” indicates the 
fluorescence that was lost during the crosslinking normalized by the corresponding controls (no 
H2O2). Mean ±s.d., n=2.  
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Figure 3.18. DAB-cytometry of 0.3:1 cholesterol:DOTAP/siRNA lipoplexes delivered to 
HeLaLuc cells as a function of time post-transfection. “Insoluble fraction” indicates the 
fluorescence that was lost during the crosslinking normalized by the corresponding controls (no 
H2O2). Mean ±s.d., n=2.  
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Figure 3.19. DAB-cytometry of 0.6:1 cholesterol:DOTAP/siRNA lipoplexes delivered to 
HeLaLuc cells as a function of time post-transfection. “Insoluble fraction” indicates the 
fluorescence that was lost during the crosslinking normalized by the corresponding controls (no 
H2O2). n =2 Error bars represent s.d.  
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Figure 3.20. Hydrodynamic diameter of polyplexes, liposomes and lipoplexes measured by DLS. 
N = 3, error bars represent s.d. 
 
Figure 3.21. Size polydispersity of polyplexes, liposomes and lipoplexes measured by DLS. N = 
3, error bars represent s.d. 
117 
 
Chapter 4. Exocytosis and endosomal escape 
4.1 Introduction 
In order to gain understanding of the intracellular kinetics of siRNA-containing particles, 
it is imperative to carefully examine the large number of events that have potential to influence 
the efficiency of the intended RNAi. Among the most frequently cited barriers that should be 
overcome in delivery of siRNA is endosomal escape, in which the siRNA is released from 
endosomes to cytosol avoiding degradation in LYs and allowing for integration into RNAi 
machinery1.  
As discussed in previous chapters, the uptake of siRNA particles generally occurs 
through endocytosis2, the innate mechanism by which cells internalize a variety of objects that 
include various protein complexes and viruses3. Following the internalization, only a fraction of 
internalized components continue to reside within the cells for prolonged periods of time, while 
the majority of the material recycles back to PMs4,5. For example, more than 99% of internalized 
receptors of transferrin have been shown to recycle back to PMs6,7. The newly internalized 
particles initially reside within primary endocytic vesicles but fuse with EEs 1 to 5 min after the 
internalization8. The sorting and maturation process in EEs causes recycling of internalized 
receptors back to PMs by separation of tubular segments (~70 nm) of EEs. The extremely 
efficient iterative process of geometric sorting removes the membrane-bound receptors with the 
bulk of the membranes that either directly travel back to replenish PMs or are delivered to 
endosomal recycling complex7,9 (also known as recycling endosomal complex, perinuclear 
recycling compartment or simply recycling endosomes). The remaining vesicular sections of EEs 
continue to acidify and mature into LEs4,10. This implies that strong association with endosomal 
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membranes might result in higher recycling rates of particles. Still, the internalization of particles 
is dependent on the attraction between the particles and the PMs. Therefore, the design of the 
delivery vectors must include promotion of interactions between the PMs and the particles to 
promote cellular attachment and internalization. The experiments presented in this chapter clarify 
the degree with which the chemical composition of vectors influences the recycling rates of the 
delivered particles. To accomplish this, cells were transfected for different time periods and the 
recycling was measured as the cells were incubated in fresh media. This allowed for an 
estimation of the rates of the “fast recycling” that occurs through EEs and the “slower recycling” 
which occurs through escape from cells via REs5. 
The majority of the materials designed for delivery of nucleic acids are tailored to 
promote “endosomal escape,” but as duly noted11, studies that attempt to describe this step often 
rely on indirect evidence of lack of colocalization of tested particles with other co-delivered 
particles that are known to follow an endolysosomal degradation path. The DAB-cytometry 
assay developed in Chapter 2 provided a means of estimation of fractions of siRNA in cytosol. 
The assay relies on preloading of all of the endocytic compartments with HRP followed by 
delivery of fluorescently labeled siRNA particles. At set times after the transfections, a DAB 
polymerization reaction was initiated that resulted in quenching of the fluorescence from all of 
the intracellular compartments that contained both the HRP and the delivered particles. The 
remaining fluorescence was attributed to siRNA that escaped to cytosol. However, this method 
relies on the assumption that HRP reaches all of the vesicles. This assumption must be verified, 
because even though HRP has been used for many decades as a marker of pinocytosis in electron 
microscopy, organelle fractionation and various studies of biological processes12–14, its fate is not 
always clear. Specifically, while a significant portion of published reports provides evidence that 
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HRP does not recycle from cells15–17, some reports suggest that it actually recycles out of the 
cells18–20. This discrepancy might be the result of the sensitivity limitations of the employed HRP 
detection assays or variation in characteristics of specific cell types that were used in these 
studies. If HRP does not reach recycling vesicles, then the DAB cytometry assay has the 
potential to overestimate the cytosolic delivery of the siRNA. Thus, in order to estimate the 
recycling rates and to verify the DAB cytometry assay, the experiments presented herein were 
conducted to study the release of the exogenous siRNA to cytosol while not being dependent on 
the co-delivery of the siRNA particles with any markers. This method is based on the ability of 
digitonin to create pores in PMs by removing some of the cholesterol from these structures. The 
resulting holes allow for an easy extraction of cytosol while preserving the internal vesicles21.  
Within the context of this dissertation, this chapter provides data on the recycling of 
siRNA delivered by the investigated vectors that will be later incorporated into a mathematical 
model used to describe endocytosis. In addition, the experiments provide confirmation and 
clarification of the investigation performed by the DAB cytometry assay presented in the 
previous chapters.  
4.2 Materials and Methods 
4.2.1 Cells, Nucleic Acids and Vectors 
HeLaLuc (luciferase-expressing cervical cancer) cells were a kind gift from Mark Davis 
group at Caltech. The culture media, culture conditions and oligonucleotides were the same as 
described in 2.2.1.  
 Branched 25 kDa PEI was used as described in 2.2.2. DOTAP and cholesterol were 
obtained from Avanti (Alabaster, AL). The lipids were first dissolved in chloroform at a 
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concentration of 10 mg/ml, mixed at ratios of 0:1, 0.1:1, 0.3:1 and 0.6:1 cholesterol:DOTAP (w:w) 
in glass tubes and placed overnight in a vacuum chamber. On the next day, the lipid layers that 
formed on the bottom of the glass tubes were suspended in PIPES buffer (20mM PIPES, 150mM 
NaCl in wate, pH 7.4r) to a final concentration of 0.2 mg/ml DOTAP using a water-bath sonicator. 
The lipid solutions were then extruded through a 100-nm polycarbonate membrane 11 times using 
Mini-Extruder setup (Avanti). Following the extrusion, the lipid stock was placed in the 
refrigerator and used in experiments on the same day. 
4.2.2 Formation of Polyplexes and Lipoplexes and Transfections 
 Polyplexes were formed at room temperature in PIPES buffer by mixing 20 µM stock 
siRNA solution with 1 mg/ml PEI solution to give a final weight ratio of 10:1 (PEI:siRNA) as 
described in 2.2.3. Similarly, siRNA was mixed with the solutions of extruded lipids in PIPES 
buffer to yield final weight ratios of 10:1 (DOTAP:siRNA). The amount of DOTAP and siRNA 
in each group was the same, but the amount of cholesterol was varied. Both types of the particles 
were incubated at room temperature for 20 min before the transfections. 
4.2.3 Digitonin extraction 
 The digitonin semi-permeabilization method21 was adapted from the work published by 
Liu et al. HeLaLuc cells were seeded in 24-well plates at the density of 0.5x105 cells/well 20 h 
before the transfections. siRNA particles were formed 20 min prior to the transfections as 
described above. Digitonin (Gold Biotechnology, St. Louis, MO) solution (20 µg/ml) was freshly 
prepared by dissolving digitonin in NEH buffer (150 mM NaCl, 0.2 mM EDTA in 20 mM 
Hepes-NaOH buffer titrated to pH 7.4  that contained 2 mM DTT and 2 mM MgCl2. The mixture 
was heated to 90°C for 10 min, cooled to 4 °C and cleared through a 0.22-µm filter as suggested 
by the manufacturer. The transfections were performed for different durations at final 
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fluorescently-labeled siRNA concentration of 5 nM in serum-free media (described in 2.2.3). 
The wells were washed with ice-cold PBS, 100 IU/ml of heparin in PBS solution followed by 
additional PBS wash. One half milliliter of digitonin solution was slowly added to half of the 
wells, and 0.5 ml of digitonin-free NEH buffer that contained 2 mM DTT and 2 mM MgCl2was 
added to the other half of the wells to serve as controls. The culture plates were placed on orbital 
shaker at 50 rpm at 4 °C for 5 min. The media was aspirated, and the wells were gently washed 
with pre-chilled PBS. Subsequently, the cells were lysed with 150 µl of 1% Triton X-100, 2% 
SDS in PBS solution and placed on orbital shaker for 30 min. One hundred microliters of the 
lysates were transferred to black 96-well plates, and the samples were diluted with additional 100 
µl of PBS before their fluorescence was measured using 620/670 nm ex/em filters on Tecan 
Infinite F200 Pro fluorometer (Männedorf, Switzerland). Fluorescence background reading 
based on lysed cells that were not transfected was subtracted from the fluorescence values of 
each sample, and the following equation was used to determine the fraction of internalized 
siRNA that was extracted with digitonin: 
𝐸𝑥𝑡𝑟𝑎𝑐𝑡𝑒𝑑 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 =
𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝑜𝑓 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 − 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝑎𝑓𝑡𝑒𝑟 𝑒𝑥𝑡𝑟𝑎𝑐𝑡𝑖𝑜𝑛 
𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝑜𝑓 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 
 As a measure of digitonin procedure efficiency and specificity, the procedure described 
above was performed with the introduction 10-kDa dextran conjugated with AF647 fluorophore 
(final concentration 50 µg/ml) instead of the siRNA particles for various times prior to 
extraction.  
4.2.4 Confocal microscopy 
 To provide support for the experiments focused on endosomal escape, siRNA particles of 
the investigated formulations were co-delivered with FITC-labeled 10-kDa dextran. The seeding 
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of HeLaLuc cells was performed as described in 2.2.5. The cells were seeded on cover glass 
slides in 6-well plates at density of 1x105 cells/well 2 days before the transfections. On the day of 
transfections, cells were pre-treated for 60 min with 2 mg/ml of FITC-dextran before the AF64- 
siRNA particles (4.2.4) were added to wells to final concentration of 5 nM. The transfections 
then proceeded for either 30 or 120 min. Afterwards, the wells were washed with ice-cold PBS, 
100 IU/ml of heparin in PBS solution and another PBS wash. The cells were then fixed with 
3.7% formaldehyde in PBS for 5 min, washed with PBS again and mounted on slides using 
ProLong Gold Antifade reagent (Thermo Fisher Scientific, Waltham, MA) that contained DAPI 
for nuclear staining. The imaging and the proceeding processing of the images were performed 
as specified in 2.2.5. That final figures represent summation of 10 z-sections containing siRNA 
(red), dextran (green) and nuclei (blue). 
4.2.5 Recycling 
 To estimate the recycling and exocytosis rates of particles during the transfections, 
HeLaLuc cells were seeded and transfected as described in 4.2.5. Transfections with the 
assembled particles were performed in 1 ml of serum-free media for 30, 60 or 120 min, after 
which, the cells were extensively washed with ice-cold PBS and heparin solution as described 
above. Three milliliters of 37 °C DMEM were added to each well, and the plates were placed in 
the incubator. When the exocytosis of polyplexes was investigated, 200 µl of media to which the 
particles escaped were withdrawn from the wells after various time intervals before the cells 
were washed and lysed. The concentration of siRNA in that media was determined using 
fluorometry by comparing the AF647 fluorescence to a standard prepared by serial dilution of 
stock of siRNA in serum-free media. For all of the samples, after various time intervals, the 
media was aspirated, and the cells were washed twice with ice-cold PBS and lysed with 150 µl 
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of 1% Triton X-100 with 2% SDS in PBS solution. One hundred microliters of the lysates were 
diluted with 100 µl of PBS. The concentration of siRNA in cell lysates was estimated using 
fluorometer and normalized to protein content as described in 2.3.1. 
 To determine the extent of exocytosis over longer period of time (>120 min), the cells 
were seeded and transfected in 24-well plates as described above. The transfections lasted for 4 
h, the media was aspirated and the cells were washed with PBS and heparin solutions. Half of the 
cells were lysed and collected as controls, while serum-containing growth media was added to 
the other half, and the cells were placed back into the incubator. After 12 h, the media was 
aspirated, and the cells were washed twice with ice-cold PBS and lysed as was done with 
controls. The siRNA content in the lysates was measured as stated above, and the values were 
normalized for the total protein content in each sample. The values of uptake of siRNA 
remaining inside of the cells after 12 h of incubation were normalized to control values to 
establish the fraction of siRNA that remained internalized. 
4.3 Results and Discussion 
4.3.1 Cytosol extraction 
 Extraction of cytosol was accomplished through the use of digitonin solution that formed 
pores in cholesterol domains in PMs. The  protocol adapted for this study was originally intended 
for use as a pre-treatment of cells before a flotation-type density separation of organelles on 
Percoll gradient21. Liu et al. went into great details and used multiple cell lines (including HeLa) 
to prove that only the cytosol and no other structures (EEs, LEs, LYs, components of PM, etc.) 
are extracted with digitonin21. Thus, the initial approach was to use this protocol to quantitatively 
estimate the release of the delivered siRNA from endocytic vesicles to cytosol. However, since 
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the membranes of internal vesicles contain large amounts of cholesterol22, it was important to 
determine the degree to which they will release their contents during the cytosol extraction 
procedure. This was accomplished through first delivering dextran to cells, and estimating the 
degree of extraction of dextran, since dextran is known to generally be confined within the 
internal vesicles after it is internalized by endocytosis23,24. As indicated in Fig. 4.1, between 
21±2% and 43±5% of the fluorescence from internalized dextran was extracted during the 
procedure. It is important to note that a limitation in this procedure is the lack of normalization 
with respect to the number of cells. Preliminary results indicated that over 80% of total protein 
(measured with BCA assay) was extracted with cytosol, as could be explained by the large 
proportion of soluble proteins in cytosol compared to the rest of the intracellular compartments25. 
Therefore, this method could only provide a semi-quantitative estimate on the degree of 
endosomal escape properties of particles, but it has potential to be greatly improved in the future. 
For example, in order to account for the cells that could be washed off the wells during the 
extraction procedure, it might be advantageous to normalize the amount of extracted material by 
the amount of DNA remaining in the samples post-extraction. In addition, parameters such as the 
concentration of digitonin, the duration of the permeabilization step, and the temperature at 
which the extractions are performed could all be optimized to specific cell and cargo types in the 
investigation. 
 When the cytosol extraction procedure was applied to cells after they were transfected 
with siRNA particles of different compositions, a peculiar pattern emerged. For polyplexes, 
73±20% of siRNA was extracted with cytosol at 5 min post-transfection, and this value rapidly 
dropped to 35±3% 25 min later and remained nearly steady through the remainder of the 
transfection (Fig. 4.2). On the contrary, ~20% siRNA was extracted at 5 min in the cases of no-
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cholesterol or 0.1:1 Chol:DOTAP vectors, but the standard deviations for these measurements 
were high due to low fluorescence signal in these samples (Fig. 4.3). The extracted fraction, 
however, increased to 35±8% and 47±10% for the no-cholesterol and the 0.1:1 Chol:DOTAP 
vectors, respectively, at 180 min. For the 0.3:1 and 0.6:1 Chol:DOTAP vectors, the extracted 
siRNA fractions at 5 min were 25±3% and 62±25% and increased to 61±21% and 87±13% at 3 h 
post-transfection, respectively (Fig. 4.4).  
Evidence from a published study indicates that the cholesterol content in membranes of 
EEs is higher than in the membranes of LEs22. As a consequence, it might be the case that the 
overestimation of siRNA in cytosol using the digitonin extraction method is associated with 
unintended disruption of EEs or REs. When comparing the digitonin extraction of polyplexes 
and dextran, only in the first two time points was more siRNA extracted from PEI/siRNA 
transfections. This could be due to high affinity of PEI to PMs (Fig. 2.3) or the high content of 
polyplexes in EEs at these time points (Fig. 2.18) that both could have contributed to the 
overestimations of the actual siRNA polyplexes located in cytosol. The data indicate that not 
substantial siRNA delivered by PEI entered cytosol during the 3 h of transfections. Nevertheless, 
even with the apparent limitations in the precision of this extraction method some important 
observations can be made.  
First, the fractions of extracted siRNA increased during the first 60 min post-transfection 
and remained relatively constant therafter. This means that as particles traveled to later endocytic 
compartments, they were not increasingly released to cytosol. This reinforces the results of the 
HRP/DAB-cytometry experiments presented in the previous chapter which showed that the 
release to cytosol occurs primarily in the early stages of endocytosis. Second, increase of 
cholesterol in lipoplexes resulted in increase of siRNA in cytosol. These data should be 
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evaluated with considerations of the near linear rates of internalization of all of the siRNA 
particles investigated in this study (Figs. 3.3-3.7). In absolute terms, the number of internalized 
particles at the beginning of the transfections is small. Therefore, one might expect practical 
experimental limits regarding the observations of the behavior of these particles with crude 
methods such as fractionation or cytosol extraction. Consequently, at later time points, the 
signal-to-noise ratio of the fluorescence is larger and allows for a higher resolution in 
measurements with conclusion of the increase in cytosol content of siRNA resulting from 
increase in cholesterol content in vectors. 
In parallel with the work presented here, another group very recently reported 
development of “nano-polyplexes” for intracellular delivery of peptides to primary coronary 
vascular muscle cells26. To demonstrate the endosomal escape mechanism of their complexes, 
they delivered fluorescently labeled complexes to cells and used digitonin-based cytosol 
extraction method nearly identical to the one used in the work presented here. Although their 
study did not require rigorous quantitative estimations of endosomal escape, Evans et al. were 
successful at demonstrating the efficacy of their constructs and usefulness of the digitonin 
extraction method applied to study intracellular trafficking of vector materials26. Therefore, the 
technique to investigate the endosomal release reported here cannot be called completely novel. 
Still, this is a relatively new protocol that when optimized, might provide a rapid and simple 
evaluation of one of the most difficult-to-study barriers in the field. 
4.3.2 Visualization of endocytic escape 
 In order to reinforce the outcomes of the digitonin semi-permeabilization experiments, 
FITC-dextran was co-delivered with fluorescently labeled siRNA complexes, and their 
intracellular distribution was observed using confocal fluorescence microscopy (Figs. 4.5-4.9). 
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As in the rest of this project, dextran served as a non-specific endocytosis marker that 
accumulates within the internal endocytic vesicles and does not reach cytosol23,24,27–29. Dextran 
can also be co-incubated with various agents, and the change of morphology or the distribution 
of dextran-labeled vesicles may be used as evidence of membrane disruption properties of these 
agents30–32. Furthermore, a simple visual observation of a punctate pattern of fluorescence within 
the cells is often used to demonstrate that the fluorescently-labeled constructs entered the cells by 
endocytosis and are confined within endocytic vesicles33,34. Therefore, the co-delivery of dextran 
with siRNA particles was performed to assess if the delivered complexes accumulate within the 
enclosed internal membranes. In addition, marked decrease in dextran-labeled vesicles or change 
in their morphology or colocalization with siRNA particles over time could serve as an indicator 
of membrane-disrupting properties of the co-delivered particles.  
The experiments were designed such that dextran was introduced to cells 60 min before 
the siRNA particles were introduced, and both stayed in the media for an additional 30 or 120 
min. Similar levels of colocalization between polyplexes and dextran could be observed with 
transfections lasting for 30 or 120 min, and no changes in morphology or overall change in 
“entrapment” of polyplexes measured by change in the number of labeled vesicles could be 
observed (Fig. 4.5). The delivery of 0:1 and 0.1:1 cholesterol:DOTAP lipoplexes was difficult to 
observe, since the number of particles within each cell was not sufficient to draw robust 
conclusions (Figs. 4.6 and 4.7). Still, it is evident that the vesicles in which 0:1 and 0.1:1 
cholesterol:DOTAP particles were enclosed were not as homogenous in size as polyplexes, and 
just like in the case of polyplexes, no major change in morphology or number of dextran-labeled 
endosomes from 30 to 120 min could be observed. The larger size of siRNA-containing vesicles 
raises the concern of significant aggregation of lipoplexes as they interact with cells, and 
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supports the results from the cytosol extraction assay that demonstrated limited ability of the 
low-cholesterol vectors and polyplexes to deliver cargo to cytosol.  
The most intriguing results were observed with transfections of 0.3:1 and 0.6:1 
cholesterol:DOTAP lipoplexes (Figs. 4.8 and 4.9). More siRNA particles could be observed after 
30 min of transfections with these cholesterol-rich complexes compared to the 0:1 and 0.1:1 
cholesterol:DOTAP lipoplexes. Nevertheless, fewer siRNA-containing vesicles could be 
observed after 120 min compared to after 30 min of transfections with 0.6:1 cholesterol:DOTAP 
vectors suggesting that the rate of formation of siRNA-enclosing vesicles was lower than the rate 
at which they released their accumulated cargo. Lipid mixing is a mechanism that is commonly 
used to explain release of nucleic acids delivered by lipoplexes to cytosol. The specifics of this 
mechanism are debated, but it certainly involves a degree of incorporation of the lipids from 
vectors into endosomal membranes35. Live-cell imaging revealed that contrary to polyplexes, 
cationic lipoplexes transfer their cargo (oligonucleotides) from endosomes to cytosol while 
retaining the synthetic lipids within endosomes for periods of over an hour36. The liposomes in 
the study presented here were not labeled, but if the mechanism by which the cholesterol-rich 
particles release their cargo involves lipid mixing, then it cannot be ruled out that an 
accumulation of vector material within the endocytic system led an to increase of the cytosolic 
delivery.  
Finally, changes in intracellular distribution of co-delivered dextran were not observed. 
This could serve as additional evidence that the endosomal escape of particles occurred in the 
earlier stages of endocytosis.  LYs/LEs are generally located closer to the nuclei compared to 
earlier-forming endocytic vesicles4, and nanocarriers commonly migrate from the periphery of 
the cells to the perinuclear space during the transfections37. It should also be noted that REs of 
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multiple types can also be found in perinuclear or pericentriolar locations within the cells7,20,38. If 
the addition or accumulation of vectors promoted endosomal escape of lipoplexes from EEs or 
REs, then it could be presumed that some dextran that was colocalized within the leaking 
vesicles escaped to cytosol as well. Consequently, less dextran would be observed in cell 
periphery compared to the perinuclear space, but this was not seen in the confocal images. 
Furthermore, some studies indicate that a fraction of internalized lipoplexes can enter cytosol 
though a direct fusion with PMs33,39, and this could be one of the mechanisms by which the 
lipoplex particles could enter the cells without affecting the observed distribution of dextran.  
Therefore, direct fusion with PMs of the lipid-based particles cannot be ruled out. These 
observations are consistent with the results from the cytosol extraction procedure that hinted on 
the cytosolic delivery primarily occurring from the early compartments. However, the confocal 
micrographs cannot be used to quantify the amount of siRNA depicted by each punctum. Rather, 
it might only indicate that the concentration of labeled particles in observed vesicles decreased 
below a threshold value. Therefore, it is reasonable to suggest that the particles or the conditions 
of transfections stimulated cells to produce more EEs, so the effective concentration of the 
particles within each vesicle decreased as the number of vesicles increased.  
4.3.3 Recycling 
 The potential recycling of internalized siRNA polyplexes and lipoplexes was investigated 
by the most commonly used40 and, perhaps, the simplest method. Two distinct but overlapping 
exocytosis routes have been well described. They can be distinguished by their kinetics (t1/2 = 5 
min vs. t1/2 = 15-30 min) and the distinct chemical characteristics of their components. In the 
faster recycling mechanism the material is moving from EEs back to PM, while in the slower 
mechanism the material is moving from EEs to REs and only then to PM9,38. Other endocytic 
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compartments have also been shown to recycle to PM8. For example, “defecation” by lysosomes 
was described as one means by which eukaryotic cells eliminate accumulated debris41,42.  
In the context of non-viral gene delivery, very few studies have reported a correlation 
between delivery efficiency in relationship to exocytosis or recycle of particles. This is especially 
evident in comparison to the large number of studies that reported the influence of endocytosis 
pathways taken by the particles as they travel to their primary site of action3. Seib et al. delivered 
different polymers that are commonly used as vectors (including PEI) to melanoma cells and 
found no “significant exocytosis” of the polymers. In contrast, 40% exocytosis of FITC-dextran 
(10 kDa) was observed within the first 10 min after the end of the delivery43. Sahay et al. 
investigated the delivery of lipid-based siRNA particles in HeLa cells, and reported the 
limitations of efficient delivery that result from recycling of particles from LEs44. However, their 
conclusions greatly relied on data obtained using confocal microscopy and might need to be 
reinterpreted. For example, they concluded that the internalized particles bypassed EEs, because 
they observed little colocalization between EE markers and siRNA 3 h after the transfections. 
This colocalization decreased as they observed the delivered siRNA exiting the cells after the 3 h 
of transfections. Interestingly, similar results were obtained in the work presented here when the 
delivery using 0.6:1 cholesterol:DOTAP lipoplexes was visualized after 2 h of transfections (Fig. 
4.9). Still, it is more likely that their particles promoted rapid escape or exit of siRNA molecules 
from EEs as opposed to bypass of this compartment. 
With the complexity and intricacies of the biology of exocytosis, the primary goal of the 
experiments presented here was to determine if the overall rates and extents of recycling of 
siRNA particles depend on the composition of the particles. In addition, the primary intracellular 
compartment from which the particles leave the cells was to be determined. To accomplish these 
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tasks, the cells were initially transfected for 30, 60 or 120 min. They were then washed with 
heparin to remove weakly PM-bound particles, and the exocytosis was monitored after additional 
washings followed by lysing of the cells and measuring their siRNA contents at different times. 
For polyplex-mediated delivery, the siRNA was also measured in the cell media (Fig. 4.10), and 
it indicated a classical biphasic profile with a fast egress of siRNA in the first 30 min followed 
by slower rates over the next 2 h. The levels of detected siRNA in cell media were nearly 
independent with respect to the initial transfection durations. This indicates that the particles that 
internalized early in the 60 and 120 min transfections had progressed into compartments that do 
not have recycling mechanism. Still, measuring the amount of particles retained within cells 
could provide a better insight into the process, since these data could be normalized to the total 
protein content (number of cells) within each sample. This method also allowed for additional 
washings of cells, reducing the possibility of erroneous result.  
With few exceptions, the experiments indicated that the fraction of the siRNA retained by 
cells is not substantially varied as the durations of transfections changed (Figs. 4.11-4.15, Table 
4.1). In other words, the manner by which the intracellular distribution of siRNA changed 
between 30 and 120 min of transfections had little influence on the retention of internalized 
siRNA. Therefore, since the accumulation of delivered oligonucleotides in later compartments of 
endocytosis had little impact on the overall recycling rates, it is evident that it is primarily the 
early compartments of endocytosis (EEs and REs) that participate in recycling. Several 
explanations can be provided for the exceptions from this general observation. For example, the 
recycle after the 30 min of delivery by 0.6:1 cholesterol:DOTAP vector (Fig.4.15) was especially 
low, but this might be explained with reference to the DAB-cytometry experiments (Fig 3.19) 
which revealed that very little amount of siRNA was located within EEs after 30 min of 
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transfections. Hence, little could be expected to recycle back to PM from that compartment. As 
the transfections proceeded for longer periods, more EEs contained some siRNA delivered by 
0:6:1 cholesterol:DOTAP lipoplexes, and the apparent recycle of these particles increased (Fig. 
4.15). Membranes of the internalized vesicles tend to recycle back to PM, while the non-bound 
contents of the vesicles tend to proceed to LYs7. As was discussed in Chapter 3, the interactions 
between the no-cholesterol particles and biological membranes are weaker compared to 
interactions between other particles and the membranes. This might explain the limited 
exocytosis observed with these complexes compared to others (Fig. 4.12).  
To conclude, Table 4.1 summarizes the overall retention of each of the investigated 
complexes as percentages of internalized siRNA at 5 min after the initiation of the transfections. 
The data indicate that even after 4 h of transfections followed by 12 h of incubation in fresh 
serum-containing media, the cells did not exocytose appreciably more siRNA than during the 
shorter transfections and shorter post-transfection incubations, leading to the conclusion of 
limited exocytosis from later endocytic organelles.  
  The errors in measurements in these experiments were high, and resulted from smaller 
number of cells per each sample compared to other experiments reported in this work. Therefore, 
the derivations of recycling rates will be performed on the basis of the observed recycling after 
the longest examined transfections of 120 min, since more delivered siRNA provided for higher 
signal-to-noise ratio, and this might be presumed to be the period at which the recycling rates 
achieved steady values. To get numerical approximations of recycling rates, a simple procedure 
was followed18,43. First, the concentrations of siRNA detected in cell lysates were normalized to 
the internalized siRNA detected 5 min after the transfections ended (Fig. 4.17). Some of the 
vectors clearly demonstrate biphasic recycling modes. For example, polyplexes likely exited the 
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cells from both the EEs and the REs in the first 30 min after the transfections. However, the 
polyplex recycling rate noticeably decreased at later times, since the particles were chased out of 
the EEs later in the process. The recycling rate of the 0.3:1 cholesterol:DOTAP particles was 
nearly constant throughout the experiments, which may indicate that these vectors did not 
participate in the rapid recycling from EEs. The recycling rates observed during the first 30 min 
correspond to an effective value comprised of a sum of the recycling from EEs and REs. Since 
the particles can be presumed to be chased out from the EEs after one hour, the exocytosis 
detected between 60 and 180 min must be originating from the RE compartment. Therefore, 
simple linear interpolation of the data (Fig. 4.17) from these time periods was performed to 
obtain quantities ( in Table 4.2) that will be integrated in the following chapter for a 
comprehensive mathematical description of intracellular kinetics.   
The intracellular location of delivered therapeutic is of central importance to the outcome 
of the treatment. The release to cytosol from the endolysosomal pathway is often cited as a 
limiting delivery step of biologics. Therefore, a variety of carriers have been designed to be 
responsive to intracellular stimuli and release the cargoes to cytosol from different 
compartments46. However, the events and mechanisms of release of biologics into cytosol are 
very challenging to study. The majority of the assays developed to study cytosolic delivery 
provide only indirect estimates of the degree of endosomal escape24. These might be excellent 
for the task of comparing vectors, but they are not sufficiently precise and consistent at providing 
data that can be integrated into a more quantitative framework. More precise methods are usually 
labor intensive and require high degree of expertise. For example, Gilleron et al. conjugated gold 
probes to siRNA and used customized image analysis algorithms to quantify large numbers of 
electron micrographs taken from 50-70 nm sections11. They reported a high degree of precision 
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in their work, but another paper that was published over 20 years ago demonstrated that the 
observed sections should be at least 100-200 nm in thickness, otherwise the tubular structures of 
EEs and REs can only be seen as small vesicles20.   
4.4 Conclusion 
With the potential limitations of the methods explored in the previous chapters, two more 
corroborative sets of evidence for the endosomal release of delivered siRNA were demonstrated 
herein. One method was based on the extraction of cytosol21, and it semi-quantitatively 
demonstrated the increase in endosomal escape of lipoplexes with the inclusion of cholesterol in 
their structures. Confocal microscopy then provided qualitative support for these results. 
However, the results from the DAB cytometry experiments will be used in the next chapter as a 
basis of the quantitative analysis of the intracellular kinetics, while the results in this chapter can 
be used in support of the DAB cytometry method.  
 Another matter explored in this chapter involved the estimation of recycling of the 
delivered siRNA. This topic is rarely discussed in the field of gene delivery, but it can have 
important implications for not only the delivery efficiency, but also on toxicity, since 
intracellular accumulation of particles is often associated with toxicity8,40. At the same time, cell 
toxicity can be a result of the unintended cytosolic release of lysosomal enzymes with the aid of 
the delivered nanoparticles. Accordingly, the design of siRNA delivery vectors will need to 
include a balanced approach to ensure avoidance of endolysosomal degradation of the siRNA as 
well as prevention of accumulation of vectors and even excessive accumulation of siRNA, since 
it was shown that saturation of RNAi machinery can have devastating effects47. Without 
accounting for exocytosis, most reports present accumulation of delivered siRNA instead of the 
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intended uptake values. For the purposes of the work presented here, it was important to 
establish the magnitude and the location from which the cells recycle the delivered siRNA. 
Surprisingly, the experiments revealed that up to half of the internalized siRNA escapes cells 3 h 
after the transfections. With the exception of the no-cholesterol DOTAP vector, very little 
variation in the extent of overall efflux was observed when siRNA was delivered with different 
vectors. This suggests that as long as substantial attraction between the vectors and the biological 
membranes exist, the particles will recycle back to the surface of cells. 
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4.6 Figures 
 
Figure 4.1. Extraction of 10-kDa FITC-dextran from digitonin-permeabilized HeLaLuc cells at 
various times after introduction of dextran. The extracted fraction was calculated by normalizing 
the fluorescence from dextran remaining inside of cells to the fluorescence from a parallel control 
groups that were not treated with digitonin as specified in 4.2.3. Mean ± s.d., n=4. 
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Figure 4.2. Extraction of siRNA from digitonin-permeabilized HeLaLuc cells at various times 
post-transfection with PEI/AF647-siRNA polyplexes. Mean ± s.d., n=4. 
 
Figure 4.3. Extraction of siRNA from digitonin-permeabilized HeLaLuc cells at various times 
post-transfection with 0:1 and 0.1:1 cholesterol/DOTAP lipoplexes. Mean ± s.d., n=4. 
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Figure 4.4. Extraction of siRNA from digitonin-permeabilized HeLaLuc cells at various times 
post-transfection with 0.3:1 and 0.6:1 cholesterol/DOTAP lipoplexes. One-way rANOVA analysis 
performed using OriginPro 9.1 software, followed by posttest using Tukey Multiple Comparisons 
Test, showed significant (p<0.05) differences between mean values of extracted siRNA delivered 
by all 4 lipoplexes with the exception of the difference between the performances of 0:1 and 0.1:1 
vectors. Mean ±s.d., n=4. 
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Figure 4.5. Representative confocal fluorescence micrographs of HeLaLuc cells transfected with 
PEI/AF647-siRNA polyplexes (red) and FITC-dextran (green) for 30 and 120 min. The images 
were generated by deconvolution and addition of 10 z-slices of the original micrographs. The 
b&w pictures represent colocalized pixels. All images are 150 X 150 µm. 
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Figure 4.6. Representative confocal fluorescence micrographs of HeLaLuc cells transfected with 
0:1 cholesterol:DOTAP lipoplexes containing AF647-siRNA (red) and FITC-dextran (green) for 
30 and 120 min. The images were generated as described in Fig. 4.5. The b&w pictures represent 
colocalized pixels. All images are 150 X 150 µm. 
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Figure 4.7. Representative confocal fluorescence micrographs of HeLaLuc cells transfected with 
0.1:1 cholesterol:DOTAP lipoplexes containing AF647-siRNA (red) and FITC-dextran (green) 
for 30 and 120 min. The images were generated as described in Fig. 4.5The b&w pictures 
represent colocalized pixels. All images are 150 X 150 µm.
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Figure 4.8. Representative confocal fluorescence micrographs of HeLaLuc cells transfected with 
0:3:1 cholesterol:DOTAP lipoplexes containing AF647-siRNA (red) and FITC-dextran (green) 
for 30 and 120 min. The images were generated as described in Fig. 4.5The b&w pictures 
represent colocalized pixels. All images are 150 X 150 µm. 
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Figure 4.9. Confocal fluorescence micrographs of HeLaLuc cells transfected with 0.6:1 
cholesterol:DOTAP vectors containing AF647-siRNA (red) and FITC-dextran (green) for 30 and 
120 min. The images were generated by deconvolution and addition of 10 z-slices of the original 
micrographs. The b&w pictures represent colocalized pixels. All images are 150 X 150 µm. 
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Figure 4.10. Exocytosis of siRNA HeLaLuc cells transfected for three different durations (30, 60 
and 60 min) with AF647-siRNA/PEI polyplexes. Cells were washed to remove weakly-attached 
complexes, and the PEI-delivered siRNA was measured in cell media at different chase periods (5 
to 180 min).  Mean ± s.d., n=4. 
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Figure 4.11.  Retention of siRNA in HeLaLuc cells transfected for three different durations (30, 
60 and 120 min) with polyplexes. The duration of the transfections is indicated by the first point 
of each curve in the figure. The cells were washed to remove weakly-bound complexes, and the 
retention of the internalized siRNA delivered by PEI was measured in cells at different chase 
periods (5 to 180 min).  Mean ± s.d., n=4. 
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Figure 4.12. Retention of siRNA in HeLaLuc cells transfected for three different durations (30, 60 
and 120 min) with 0:1 lipoplexes. The duration of the transfections is indicated by the first point 
of each curve in the figure. The cells were washed to remove weakly-bound complexes, and the 
retention of the internalized siRNA delivered by the lipoplexes was measured in cells at different 
chase periods (5 to 180 min).  Mean ± s.d., n=4. 
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Figure 4.13. Retention of siRNA in HeLaLuc cells transfected for three different durations (30, 60 
and 120 min) with 0.1:1 lipoplexes. The duration of the transfections is indicated by the first point 
of each curve in the figure. The cells were washed to remove weakly-bound complexes, and the 
retention of the internalized siRNA delivered by the lipoplexes was measured in cells at different 
chase periods (5 to 180 min).  Mean ± s.d., n=4. 
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Figure 4.14. Retention of siRNA in HeLaLuc cells transfected for three different durations (30, 60 
and 120 min) with 0.3:1 lipoplexes. The duration of the transfections is indicated by the first point 
of each curve in the figure. The cells were washed to remove weakly-bound complexes, and the 
retention of the internalized siRNA delivered by the lipoplexes was measured in cells at different 
chase periods (5 to 180 min).  Mean ± s.d., n=4. 
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Figure 4.15. Retention of siRNA in HeLaLuc cells transfected for three different durations (30, 60 
and 120 min) with 0.6:1 lipoplexes. The duration of the transfections is indicated by the first point 
of each curve in the figure. The cells were washed to remove weakly-bound complexes, and the 
retention of the internalized siRNA delivered by the lipoplexes was measured in cells at different 
chase periods (5 to 180 min).  Mean ± s.d., n=4. 
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Figure 4.16. Retention of siRNA delivered by the investigated vectors in HeLaLuc cells measured 
12 h after 4-h of transfections.  Mean ± s.d., n=4. 
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Figure 4.17. Kinetics of recycling of the investigated vectors in HeLaLuc cells. HeLaLuc cells 
were transfected with the investigated vectors for 2 h. The cells were washed and chased in 
serum-free media for the durations indicated on the x-axis. The cells were then lysed, and their 
content of delivered siRNA was assayed as described in section 4.2.5. The siRNA-content values 
from the various chase times were normalized to the siRNA-content value detected after 5 min of 
chase. Mean ± s.d., n=4. 
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Table 4.1. Summary of the retention values of delivered complexes 
Vector 
composition 
Internalized siRNA remaining in cells 3 h after the 
transfections (%); duration of the transfections 
indicated below  
siRNA retained 
by cells 12 h 
after 4-h 
transfection 
 30 min 60 min 120 min  
PEI 62±12.0 62±9.5 53±8.3 50±8.2 
0.6:1 
Chol:DOTAP 
116±45.2 66±18.0 69±9.4 55±15.8 
0.3:1 
Chol:DOTAP 
73±19.8 76±19.6 77±16.8 61±11.0 
0.1:1 
Chol:DOTAP 
62±16.3 61±18.2 72±14.4 58±11.1 
0:1 
Chol:DOTAP 
65±26.4 66±28.6 88±16.7 81±9.4 
 
Table 4.2. Recycle rates  
 PEI cholesterol:DOTAP 
0:1 0.1:1 0.3:1 0.6:1 
Recycle rate from EEs 
(1/min) 
0.010 0 
(estimated) 
0.0032 0.00095 0.0079 
Recycle rate from REs 
(1/min) 
0.0012 0.0016 0.00095 0.00086 0.00035 
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Chapter 5. Model-based investigation and interpretation of siRNA delivery systems 
5.1 Introduction 
 Model-based approaches to study nucleic acids delivery systems can be used to 
quantitatively describe delivery barriers, explain the impact of the chemical composition of the 
delivery vectors on the therapeutic efficiency and guide the developments of the delivery vectors1,2. 
Generally, two different modeling approaches can be found in the literature. The simplest approach 
consists of construction of sets of first-order ordinary differential equations (ODEs) that describe 
the mass action kinetics of endocytosis and transport among endocytic vesicles3–7. In this approach 
the intracellular transport between the compartments is represented by the kinetics constants with 
the underlying assumption that the modeled compartments are well mixed. To quantitatively 
describe the intracellular kinetics, the parameters within the proposed sets of ODEs are optimized. 
In other words, the parameters that minimize the difference between the experimental kinetics data 
and the dependent variables within the proposed sets of ODEs are effective representatives of the 
transport phenomenon.  
A more recently proposed approach consists of a more robust method of mathematical 
description that includes stochastic components implemented as first-order Markov processes8. 
This concept, also known as “discrete nanoscale transport,” is able to include the descriptions of 
small-scale events such as microtubule-dependent movements, specific membrane recognition and 
tethering and influence of local concentrations of components on the transport events9.  However, 
discrete nanoscale transport modeling requires large sets of data obtained by single-particle 
tracking experiments. These experiments are more challenging to perform compared to the 
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macroscopic-type experiments in which the average properties of large populations of cells are 
measured.  
Both of the approaches are capable of describing major intracellular transport processes 
that limit the delivery efficiency, and both have been shown to provide similar conclusions 
regarding the general nature of the explored delivery systems10. Nevertheless, only the more robust 
approach has predictive abilities and is truly capable of resolving many of the mechanistic 
properties of the delivery systems. For example, the fundamental limitation of non-viral gene 
delivery vectors compared to the viral-based delivery was shown to be due to the absence of 
transport machinery of the naked DNA from the cytosol to the nucleus and the degradation of the 
DNA during this transport step. The researchers were even able to predict and explain an upper 
limit that could be achieved with modifications of synthetic vector materials on the successful 
DNA transfections compared to viruses8. Interestingly, even though their analysis was based on 
DNA-containing polyplexes, it suggests that in the absence of the optimal location within the 
cytosol for the siRNA delivery, the biggest hurdle concerning the DNA transfections is nonexistent 
for the siRNA delivery. 
The study presented in this dissertation mainly focuses on the development of the 
experimental methods that provide data on the rates with which the internalized nucleic acids reach 
their ultimate locations. These are important, since the overall majority of the published models 
contain mixed transport data obtained from different cell lines, different culture conditions and 
even different vectors within a single model. For example, Bartlett et al. used a comprehensive set 
of 12 ODEs with 29 parameters to describe the RNAi resulting from siRNA delivered using 
commercially available vector or PEI-based material to different cells in vivo and in vitro5. The 
main objective of their study was to investigate the dependence of the RNAi on the division rate 
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of cells. Out of the 29 parameters used in the model, 16 were taken from studies in the literature 
that described different cell lines. In addition, some arbitrary assumptions regarding the 
transfection efficiency (percentage of transfected cells out of the total population) were made to 
“provide best fit to experimental results.” This implies that these assumptions had pronounced 
effect on the model; consequently, they express real biological events that have to be specific for 
different experimental conditions and cannot be presented as an algebraic exercise. The authors 
only provided data on the RNAi knockdown and acknowledged that the accuracy of the transport 
parameters was not as important for the objectives of the study as the ability to model the 
investigated correlation between the RNAi efficiency and the rates of cells division. Still, it is 
likely that different cell lines not only have different rates of growth but also differ in their 
capacities to regulate the storage and release of the internalized siRNA into the cytosol11 or in their 
capacities to exocytose the material12 or even degrade it at different rates.  
Varga et al. presented a model that contained 15 ODEs with 9 parameters 3. Their 
publication contains a table with the description of kinetic rate constants, and it clearly states that 
four of the parameters were fitted from the experimental data. However, their Results section states 
that they first assumed unpackaging and endosomal escape “to be instantaneous when coupled to 
binding and internalization of complexes,” while the above mentioned table lists the endosomal 
escape parameter value of 1x10-2 min-1 and the vector unpacking parameter value as 1x109 min-1. 
In addition, they later state that only two parameters “were combined and fit from the experimental 
data.” They also provided validation of their model by applying it to describe previously published 
data that provided a correlation between the unpackaging rate of vectors and their delivery 
efficiency. If the proposed model assumed instantaneous unpackaging and endosomal escape, then 
it is not clear how they were successful at employing it to predict the dependence of the gene 
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delivery efficiency on the unpackaging rate constant. Unfortunately, many other published reports 
that contain modeling components only further add to the confusion: out of about a 1000 published 
models of biological systems only 0.5% could be successfully reproduced13.   
Hence, the modeling that is reported in this chapter will include the simplest approach and 
be based on the data that were presented in the previous chapters. The models might not be 
sufficiently robust to provide predictive behavior of the investigated systems, but they will still be 
useful in demonstrating fundamental qualities of the investigated vectors. The objective of the 
optimizations of the models performed herein is mainly to create a unified presentation of the 
intracellular kinetics of the lipo- and polyplexes and explore how their physical characteristics 
contributed to their delivery activities.      
5.2 Materials and Methods 
5.2.1 Description of the mathematical model 
 Mass action kinetics were represented by a series of first order ODEs (Eqns. 1-7) and is 
depicted in Fig. 5.1. The description of the kinetics parameters is summarized in Table 5.1. Briefly, 
M represents the total number of siRNA molecules in the media per each cell. The particles could 
transfer from media (M) to cells by first attaching to PMs with kMP as a rate constant. They could 
also enter cytosol through the PMs by some passive events such as direct fusion with PMs14,15 or 
by pores formed in PMs16. Thus, the particles could potentially enter cytosol without active 
endocytosis process with minimal interactions with PMs (kMC). In addition, the particles could 
directly attach to the receptor clusters on PMs or sections of PMs in the process of invagination 
and be carried to EEs (kMEE).  Because of the heterogeneous nature of the particles, some might 
have spent more time on PMs before they internalized through either active endocytosis (kPEE) 
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or entered cytosol (C) directly from PMs by some sort of passive uptake process (kPC). Since data 
concerning the accumulation of particles on PMs could be incorporated into the model (Figs. 3.8 
and 3.9), it was useful to separately include kinetics terms that describe the influence of this 
accumulation on the internalization (kMP, kPC, kPEE) and terms that represent transport from the 
culture media to cells avoiding this accumulation (kMC, kMEE). Once in EEs, particles could 
recycle back to PMs (kEEP), migrate to REs (kEERE), translocate to LEs (kEELE) or be released 
to C (kEEC). Once in REs, the complexes could migrate back to PM through a slower recycling 
process (kREP) or be released to C (kREC). From the LEs, the particles might access C (kLEC) 
or enter LYs (kLELY). The particles that entered LYs likely degraded (kDLY). In addition, some 
mechanism similar to autophagy could carry the particles to from C to LYs (kCLY).  
𝑑𝑀
𝑑𝑡
= −(𝑘𝑀𝑃 + 𝑘𝑀𝐶 + 𝑘𝑀𝐸𝐸)𝑀       (Eqn. 1) 
𝑑𝑃
𝑑𝑡
= 𝑘𝑀𝑃𝑀 + 𝑘𝐸𝐸𝑃𝐸𝐸 + 𝑘𝑅𝐸𝑃𝑅𝐸 − (𝑘𝑃𝐸𝐸 + 𝑘𝑃𝐶)𝑃    (Eqn. 2) 
𝑑𝐸𝐸
𝑑𝑡
= 𝑘𝑃𝐸𝐸𝑃 + 𝑘𝑀𝐸𝐸𝑀 − (𝑘𝐸𝐸𝑅𝐸 + 𝑘𝐸𝐸𝐿𝐸 + 𝑘𝐸𝐸𝐶  + 𝑘𝐸𝐸𝑃)𝐸𝐸  (Eqn. 3) 
𝑑𝑅𝐸
𝑑𝑡
= 𝑘𝐸𝐸𝑅𝐸𝐸𝐸 − (𝑘𝑅𝐸𝑃+𝑘𝑅𝐸𝐶)𝑅𝐸        (Eqn. 4) 
𝑑𝐿𝐸
𝑑𝑡
= 𝑘𝐸𝐸𝐿𝐸𝐸𝐸 − (𝑘𝐿𝐸𝐿𝑌 + 𝑘𝐿𝐸𝐶)𝐿𝐸       (Eqn. 5) 
𝑑𝐿𝑌
𝑑𝑡
= 𝑘𝐿𝐸𝐿𝑌𝐿𝐸 + 𝑘𝐶𝐿𝑌𝐶 − 𝑘𝐷𝐿𝑌𝐿𝑌        (Eqn. 6) 
 
𝑑𝐶
𝑑𝑡
= 𝑘𝑃𝐶𝑃 + 𝑘𝐸𝐸𝐶𝐸𝐸 + 𝑘𝐿𝐸𝐶𝐿𝐸 + 𝑘𝑅𝐸𝐶𝑅𝐸 + 𝑘𝑀𝐶𝑀 − 𝑘𝐶𝐿𝑌𝐶   (Eqn. 7) 
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5.2.2 Data for parameter optimizations 
In all of the experiments, the siRNA was introduced to cells at a final concentration of 5 
nM, which resulted in ~ 3.07x1011 siRNA molecules in each ml of media, using the molecular 
weight of theAF647-conjugated siRNA molecules provided by the manufacturer. It is a common 
practice5,6 to simply estimate the number of available particles for internalization into cells. The 
experiments indicated that the amount of internalized siRNA is much smaller than the amount of 
siRNA in the media during the transfections (Figs. 5.2-5.6). Hence, using the transfection 
procedure described in 3.2.2 as a calculations basis, the initial number of siRNA molecules 
available to each cells was assumed to be 3.07x107. As mentioned above, the accumulation of 
particles on PMs was estimated by subtracting the values of the total association of particles with 
cells from the values of the particles that internalized (Figs. 3.3-3.7). Those values were converted 
to siRNA molecules/cell by earlier experiment-based estimations that each HeLaLuc cell 
contained ~125 pg of protein. This estimate is consistent with published values of 150 pg/cell17. 
The values of the intracellular distribution of particles were all based on the DAB-cytometry 
experiments (Figs. 2.18 and 3.16-3.19).  
5.2.3 Implementation of the model  
All of the parameter estimations, model simulations and sensitivity analysis were 
performed using open source JSim ver. 2.16 software13,18. The Mathematical Modeling Language 
(MML) was used to input Eqns. 1-7, and the experimental data were supplied in a separate 
computer file. To avoid misinterpretation of the data, the first two data points that described the 
kinetics after 5 and 15 min of transfections were not included in the loaded dataset. Attempts were 
made to include the two time points into the optimization routine, but they caused inconsistent 
convergence of the optimization solutions. Since the initial time data points were obtained with 
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the lower signal-to-noise ratio conditions compared to the later points, a decision was made to omit 
these points from the parameter optimization routine for all of the studied vectors. A non-linear 
bounded steepest-descent algorithm was used for the estimation of the parameter values19. The 
initial conditions of the dependent variables were all set to 0, and all of the rate coefficients were 
bounded between 0 and 1 min-1. In addition, more weight was given to the experimental values 
obtained at later time points of transfections, because of higher signal-to-noise ratio of these 
samples. The weighting function was defined as 1+0.01*t. 
Built-in Monte Carlo method was used to estimate the standard deviations of the optimized 
parameters. The program generated 10 random sets of pseudo-data with Gaussian distribution 
around the experimental data (up to 10% deviation from the data), and the optimization of the 
parameters was performed for each set. The optimized values for each set of pseudo-data were 
then used to estimate the standard deviations of the optimized parameters. This method can also 
be used as a sensitivity analysis, since it relates the variations of outcomes of the models 
(dependent variables) with the parameters. 
A sensitivity analysis was also performed to determine the limiting step in the siRNA 
delivery. Each optimized parameter was systematically increased by 20% manually, the 
simulations were carried out, and the simulated siRNA content in EEs, C or total uptake at t = 190 
min were normalized to the values in these compartments at t = 190 min before the 20% 
perturbations. 
5.3 Results and Discussion 
The simplest quantitative model describing the multicompartmental nature and first-order 
kinetics of intracellular events of delivered non-viral complexes were first presented 21 years ago20. 
163 
 
Still, these types of useful quantitative interpretations of experimental data are not commonly 
performed to explain the behaviors of the delivered complexes. This is especially in contrast to the 
attempts to experimentally elucidate the impact of modifications of vectors on the behavior of the 
internalized particles by the use of chemical reagents21,22 or alterations of the cells (e.g., creation 
of dominant negative clones or RNAi modifications). It is most desirable, however, to study the 
intracellular transport without alterations of native biological processes.  
Many of the frequently explored steps and frequently disputed phenomena of nucleic acids 
delivery such as endosomal escape mechanisms23 or endocytosis pathways24 could potentially be 
elucidated if the experimental data were explored with the use of comprehensive mathematical 
models. For example, it is well known that the endocytosis pathways by which cells internalize 
materials differ in their rates25. Therefore, just like a model-based examination of internalization 
and trafficking of DNA complexes revealed the separate contributions of the active transport and 
passive diffusion toward the translocation of the particles across biological membranes26, so could 
similar model explain the relative contributions of different endocytosis pathways taken by various 
complexes. The possible reason for this apparent deficiency in analysis of experimental data could 
be the lack of sensitive and easy-to-implement assays that can provide information on intracellular 
distribution of the investigated particles. Vast amounts of reliable data should be available for 
different cell types and experimental conditions in order to take advantage of the robust discrete 
nanoscale transport models. As was discussed in Chapter 2, the methodology required for the 
collection of these data requires particle-tracking experiments and confocal microscopy that is 
difficult to master.  
It is particularly difficult to study the endosomal escape process23. For example, Pinel et al. 
reported a limited quantitative study of the delivered siRNA to cells with a PEI-based vector27. 
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They stated that “cytosolic siRNA concentrations are unfortunately difficult to measure” and had 
to base a quantitative estimation of the content of siRNA in cytosol on the measured RNAi induced 
by the delivered oligonucleotides27. Even if the robust data on the intracellular behavior of the 
particles is available, the computational demand can be very costly28 and require great levels of 
expertise to implement. A call has been made to establish multidisciplinary collaboration to 
perform robust quantitative studies into the pharmacokinetics/pharmacodynamic properties of 
delivery vectors, since these would require deep expertise in both the experimental techniques and 
the quantitative modeling1.   
The initial optimization of the parameters provided a reasonably good fit to the 
experimental data (Figs. 5.2-5.6). Table 5.5 provides residual sums of squares of the fits. The best 
fit was obtained for the 0:1 vectors and the poorest for the PEI vectors. This could be because of 
multiple factors, but a poor fit to the experimental model might imply an inadequacy within the 
mathematical structure. One of the main assumptions in the models is that the rate constants remain 
unchanged during the experiments. However, since the toxicity of PEI is high29, it was not easy to 
fit the model to the data.  
The sensitivity analysis showed that an increase in 20% in the ability of polyplexes to bind 
to PMs could increase the siRNA content in cytosol by nearly 16% (Fig. 5.7). Increasing the 
clearance from the cytosol to LYs (kCLY) by 20% could also decrease the cytosol content of PEI-
delivered siRNA by nearly 17%. Interestingly, the analysis revealed that 20% increase in the rate 
constants corresponding to release to cytosol from EEs or LEs would have impact of less than 10% 
on the final siRNA content in cytosol, with the release from LEs to have greater impact. 
Surprisingly, many of the parameters, including kMC had nearly negligible impact on the final 
concentration of delivered siRNA.  
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Regarding the lipoplexes, it is expected that the 20% increase in the direct translocation 
from culture media to cytosol will have the biggest impact (slightly over 19% increase) on the 
siRNA delivery to cytosol (Figs. 5.8-5.11). As discussed in previous chapters, more siRNA 
internalized with the increase in cholesterol content of lipoplexes. The sensitivity analysis 
demonstrates that this was a consequence of increase of the ability of the lipoplexes to directly 
fuse with PMs rather than attach to some receptors on PMs or gain additional endosomal-escape 
benefits. Just like in the case of the sensitivity analysis with polyplexes, increase in many of the 
parameters in lipoplex models did not have detectable change on the outcomes of the simulations. 
This could explain the success of others in their modeling outcomes3–5, despite the usage of a great 
number of parameters from different experimental conditions within the same models.  
The optimization of the parameters also included a Monte Carlo –type simulation of a noise 
in the data that allowed estimating the standard deviations of the parameters. It was surprising to 
discover that many of the parameters have standard deviations much larger than the mean values 
(bold number in Table 5.2). Essentially, the random noise in the data could not impact the 
optimization parameters. This, however, does not mean that the model or the data are flawed, but 
simply is an important property of the system that should be taken into consideration during the 
future designs of the experiments in siRNA or gene delivery (“reverse engineering”)30,31.  
The “reduction” or a simplification of a model is sometimes used to simplify the 
mathematical description of the modeled systems, but these should be carefully performed to avoid 
the elimination of the essential elements within the mathematical model32. The high standard 
deviations in some parameters, in part, mean that the experimental design or the nature of the 
system could not be recorded or documented mathematically. The parameter kPC had large 
standard deviation in all of the vectors (Table 5.2). In addition, the parameter kREC had large 
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standard deviations in all of the vectors except in the case of the 0.6:1 Cholesterol:DOTAP 
lipoplexes. However, very small number of particles were in the simulated RE compartment of 
this vector, so the optimized parameter might not be a great contributor to the success of the 
modeling. Thus, the simulations were carried out again with parameters kREC and kPC set to 0 
(Table 5.4). Reduction in the number of parameters is expected to increase the sums of the residuals. 
However, for the 0:1, 0.1:1, 0.3:1 vectors, the sums of squares of the residuals decreased, while 
they only marginally increased for the other two vectors (Table 5.4). This is likely because the 
optimization routine had a smaller parameter vector space, so more iterations could be performed 
around the parameters that influenced the fits the most. Still, this does not mean that REs did not 
release any siRNA to cytosol or that once attached to PMs, the particles did not translocate directly 
into the cytosol. This, however, implies that either the experimental data, the nature of the system, 
or the optimization routine were not sufficient for the optimizations of the two parameters that 
were set to 0.  
The results of the new model are compared to the experimental data in Figs. 5.12-5.16. The 
sensitivity analysis on the new parameters was performed again, and it yielded similar trends as 
with the full 16-parameter models (Figs. 5.17-5.21). Mainly, the 20% increase in attachment of 
the polyplexes to PMs could be a great contributor to the siRNA delivery to cytosol, while an 
increase by 20% in the capacity of the polyplexes siRNA to escape EEs or LEs would likely not 
provide great benefit for the cytosolic delivery. The repeated analysis with lipoplexes also showed 
similar trends and importance of the direct fusion with PMs for these types of vectors. In practical 
terms, this could be implemented by the attachment of targeting moieties on polyplexes, but the 
attachment of those on lipid-based vectors might not make them more efficient at delivering the 
material to the cytosol.  
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To refer this to a more specific case, our group performed studies aimed to learn more 
about the relative contributions of endocytosis pathways to gene and siRNA delivery. To 
accomplish this task, various polymer-based vectors were functionalized with ligands that are 
known to enter cells through specific pathways33,34. However, even the ligands that led polyplex 
internalizations toward less beneficial pathway in gene delivery provided higher transfection 
efficiency compared to the cases in which the polymers did not have any targeting molecules. Thus, 
increased attachment to PMs yielded higher transfection efficiency.  
In the case of lipoplexes and siRNA delivery, Hayashi et al. published a study in which 
they coated siRNA/PEI particles with lipid material35. They delivered their complexes both in vitro 
and in vivo. They reported very strong correlation between the observed knockdown and the total 
number of the siRNA molecules delivered to cells in both cases, but since less siRNA entered cells 
in the in vivo setting, they observed smaller knockdown in vivo compared to in vitro. Hence, the 
particles that entered the cells induced RNAi without significant interference as a consequence of 
being trapped in the endolysosomal system. This is despite the fact that the endosomal escape of 
the polymer-based vectors is frequently cited as a limiting step in the efficient delivery of the 
nucleic acids23,36–38. Therefore, it is evident that the lipid-coating of the particles explored by 
Hayashi and colleagues allowed the particles to enter cytosol from the extracellular environment 
avoiding the endosomal entrapment35. This type of internalization process was characterized by 
the kMC parameter that was shown to be the limiting (and the driving) process by the sensitivity 
analysis for the lipoplexes described above.  
Finally, the content of the siRNA delivered by all of the investigated vectors as a function 
of transfection durations is compiled in Fig. 5.22. Comparing the cytosolic content of siRNA to 
the uptake measured by the flow cytometry (Fig. 3.2) shows that the trend of increased 
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internalization of lipoplexes with increased cholesterol content in lipoplexes is consistent with the 
increase in the siRNA content in cytosol for these vectors. The median values of internalization of 
siRNA delivered by PEI were similar to the uptake values when 0.1:1 lipoplexes were used. At the 
same time, the average values from the flow cytometry experiments describing the uptake with an 
aid of PEI showed it to be capable of delivering siRNA close to the levels of 0.6:1 vector. The 
similarity between the average total amount of delivered siRNA by PEI and by 0.6:1 could also be 
observed when the uptake was measured in cell lysates (Figs. 3.6 and 3.7). This was explained by 
the great geometric heterogeneity of the formed PEI particles. Thus, only subpopulation of 
polyplexes entered the cytosol compared to an association between the total uptake and the 
presence in the cytosol in the cases of the lipid-delivered siRNA.  
Therefore, an attempt was made to quantitatively determine the location from which siRNA 
enters cytosol when delivered by PEI. This was initially accomplished by running additional 
optimizations of parameters of the simplified mathematical model fitted to the data from the PEI-
delivery experiments. Two cases were explored: either kEEC or kLEC were set to 0, and the 
parameter optimization routines were carried out. This “forced” the optimization of parameters 
based on a model that either does not permit endosomal escape from EEs or LEs to the cytosol. 
The newly optimized parameters are listed in Table 5.4. To compare the goodness-of-fits obtained 
by these optimizations, the Akaike’s Information Criterion (AICc) method was employed. In a 
nutshell, this powerful method is “difficult to follow” mathematically, but “it combines maximum 
likelihood theory, information theory, and the concept of entropy of information (really!).39” It is 
very easy to implement, and it results in scores for different models that can be compared to 
ultimately decide “on which model is more likely to be correct.39” In the two explored cases the 
AICc value is smaller when kLEC was set to 0 compared to the case when kEEC was set to 0. This 
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means that the evidence ratio (probability that the model with kEEC set to 0 is correct divided by 
the probability that the model with kLEC set to zero is correct) is close to 98 in favor of the escape 
from EEs rather than from LEs to the cytosol. In addition, the derivatives of siRNA content in 
cytosol were plotted as a function of the transfection durations (Fig. 5.23). For all of the lipoplexes, 
the maximum rate of change was at the very beginning of the transfections, while this value peaked 
at 14 min in the case of the delivery with PEI. Therefore, unlike the lipid-based vectors, PEI 
provided detectable endosomal escape of the siRNA likely from the EEs at 14 minutes after the 
transfections began. With the lipoplexes, the rate of delivery to cytosol was the highest at the 
beginning of the experiments, supporting the evidence of siRNA delivery to cytosol by direct 
fusion with PMs.  
5.4 Conclusion 
 The mathematical analysis of the data that described the intracellular distribution of the 
siRNA delivered by the explored vectors provided useful insights into the mechanisms by which 
the siRNA enters the cytosol. Lipid-based vectors employ a mechanism of direct fusion with PMs 
to translocate their cargoes to cytosol. Increase in the cholesterol content of the lipid-vectors 
enhanced the ability of the direct fusion and resulted in greater delivery of siRNA to the cytosol. 
In contrast, PEI delivered siRNA to cytosol from the EEs compartment with the maximum rate at 
14 min after the transfections began. In addition, improved attachment of polyplexes to PMs might 
greatly improve the delivery of siRNA into cytosol, while such improvement in the case of 
DOTAP/cholesterol vectors might not be as dramatic. The analysis also helped to explain the 
success of the mathematical approach in the cases where mixed parameters from different 
experimental conditions are applied in one model. However, caution should be exercised in these 
cases, since there is no guarantee that mixing of the parameters and using order-of-magnitude 
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estimates of the parameters will always allow for a comprehensive analysis of the delivery systems. 
Therefore, the DAB-cytometry and other assays that could be used to estimate the intracellular 
distribution of the delivered cargoes in a simple and unambiguous way are instrumental to the 
continuation of the development of the materials for the delivery of nucleic acids and other 
potential cargoes.  
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5.6 Figures 
 
Figure 5.1. Pictorial representation of the proposed model with parameters included in Eqns. 1-7 
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Figure 5.2. Model consisting of Eqns. 1-7 with optimized parameters (Table 5.2) based on the 
experimental data of siRNA delivery by PEI vector in HeLaLuc cells (Figs. 2.18 and 3.7). The 
points on the graphs represent experimental data (mean±s.d.), and the lines depict the optimized 
model. 
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Figure 5.3. Model consisting of Eqns. 1-7 with optimized parameters (Table 5.2) based on the 
experimental data of siRNA delivery by 0:1 (Cholesterol:DOTAP) vector in HeLaLuc cells. 
The points on the graphs represent experimental data (Figs. 3.3 and 3.16) (mean±s.d.), and the 
lines depict the optimized model. 
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Figure 5.4. Model consisting of Eqns. 1-7 with optimized parameters (Table 5.2) based on the 
experimental data of siRNA delivery by 0.1:1 (Cholesterol:DOTAP) vector in HeLaLuc cells. 
The points on the graphs represent experimental data (Figs. 3.4 and 3.17) (mean±s.d.), and the 
lines depict the optimized model. 
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Figure 5.5. Model consisting of Eqns. 1-7 with optimized parameters (Table 5.2) based on the 
experimental data of siRNA delivery by 0.3:1(Cholesterol:DOTAP) vector in HeLaLuc cells. 
The points on the graphs represent experimental data (Figs. 3.5 and 3.18)  (mean±s.d.), and the 
lines depict the optimized model. 
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Figure 5.6. Model consisting of Eqns. 1-7 with optimized parameters (Table 5.2) based on the 
experimental data of siRNA delivery by 0.6:1 (Cholesterol:DOTAP) vector in HeLaLuc cells. 
The points on the graphs represent experimental data (Figs. 3.6 and 3.19) (mean±s.d.), and the 
lines depict the optimized model. 
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Figure 5.7. Sensitivity analysis of influence of 20% increase in the optimized parameters on the 
siRNA delivered by PEI in early endosomes (EEs), cytosol (C) and overall uptake. 
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Figure 5.8. Sensitivity analysis of influence of 20% increase in the optimized parameters on the 
siRNA delivered by 0:1 cholesterol:DOTAP vector in early endosomes (EEs), cytosol (C) and 
overall uptake. 
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Figure 5.9. Sensitivity analysis of influence of 20% increase in the optimized parameters on the 
siRNA delivered by 0.1:1 cholesterol:DOTAP vector in early endosomes (EEs), cytosol (C) 
and overall uptake. 
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Figure 5.10. Sensitivity analysis of influence of 20% increase in the optimized parameters on the 
siRNA delivered by 0.3:1 cholesterol:DOTAP vector in early endosomes (EEs), cytosol (C) 
and overall uptake. 
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Figure 5.11. Sensitivity analysis of influence of 20% increase in the optimized parameters on the 
siRNA delivered by 0.6:1 cholesterol:DOTAP vector in early endosomes (EEs), cytosol (C) 
and overall uptake. 
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Figure 5.12. Model consisting of simplified Eqns. 1-7 with optimized parameters (Table 5.3) 
based on the experimental data of siRNA delivery by PEI vector in HeLaLuc cells. The points 
on the graphs represent experimental data (mean±s.d.), and the lines depict the optimized model. 
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Figure 5.13. Model consisting of simplified Eqns. 1-7 with optimized parameters (Table 5.3) 
based on the experimental data of siRNA delivery by 0:1 cholesterol:DOTAP vector in 
HeLaLuc cells. The points on the graphs represent experimental data (mean±s.d.), and the lines 
depict the optimized model. 
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Figure 5.14. Model consisting of simplified Eqns. 1-7 with optimized parameters (Table 5.3) 
based on the experimental data of siRNA delivery by 0.1:1 cholesterol:DOTAP vector in 
HeLaLuc cells. The points on the graphs represent experimental data (mean±s.d.), and the lines 
depict the optimized model. 
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Figure 5.15. Model consisting of simplified Eqns. 1-7 with optimized parameters (Table 5.3) 
based on the experimental data of siRNA delivery by 0.3:1 cholesterol:DOTAP vector in 
HeLaLuc cells. The points on the graphs represent experimental data (mean±s.d.), and the lines 
depict the optimized model. 
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Figure 5.16. Model consisting of simplified Eqns. 1-7 with optimized parameters (Table 5.3) 
based on the experimental data of siRNA delivery by 0.6:1 cholesterol:DOTAP vector in 
HeLaLuc cells. The points on the graphs represent experimental data (mean±s.d.), and the lines 
depict the optimized model. 
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Figure 5.17. Sensitivity analysis of influence of 20% increase in the optimized and simplified 
parameters (Table 5.3) on the siRNA delivered by PEI vector in early endosomes (EEs), cytosol 
(C) and overall uptake. 
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Figure 5.18. Sensitivity analysis of influence of 20% increase in the optimized and simplified 
parameters (Table 5.3) on the siRNA delivered by 0:1 cholesterol:DOTAP vector in early 
endosomes (EEs), cytosol (C) and overall uptake. 
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Figure 5.19. Sensitivity analysis of influence of 20% increase in the optimized and simplified 
parameters (Table 5.3) on the siRNA delivered by 0.1:1 cholesterol:DOTAP vector in early 
endosomes (EEs), cytosol (C) and overall uptake. 
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Figure 5.20. Sensitivity analysis of influence of 20% increase in the optimized and simplified 
parameters (Table 5.3) on the siRNA delivered by 0.3:1 cholesterol:DOTAP vector in early 
endosomes (EEs), cytosol (C) and overall uptake. 
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Figure 5.21. Sensitivity analysis of influence of 20% increase in the optimized and simplified 
parameters (Table 5.3) on the siRNA delivered by 0:6  cholesterol:DOTAP vector in early 
endosomes (EEs), cytosol (C) and overall uptake 
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Figure 5.22. Compilation of the detected siRNA in cytosol (points) and the simplified models 
optimized to describe the process (Table 3) as a function of transfection durations 
 
Figure 5.23. Instantaneous rates of change of siRNA in cytosol with respect to time plotted as a 
function of the transfection durations obtained from the simplified and optimized model 
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Table 5.1. Description of the kinetics parameters 
Parameters Description 
kMP Complex binding to PM 
kREP Transport from RE to PM 
kPEE Internalization from PM to EE 
kPC Movement from PM to C 
kEERE Translocation from EE to RE 
kEELE Transport from EE to LE 
kEEC Endosomal escape from EE to C 
kLELY Transport from LE to LY 
kLEC Escape from LE to C 
kDLY Degradation in LY 
kEEP Recycle from EE to PM 
kMC Passive internalization from media to C 
kMEE Endocytosis not involving aggregations/residence on PM 
kREC Release to C from RE 
kCLY Autophagy 
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Table 5.2. Optimized rate parameters values based on the full proposed model. The bold values 
represent standard deviations higher than the mean values. 
PEI 0:1 0.1:1 
Parameters 
(1/min) 
mean s.d. mean s.d. mean s.d. 
kMP 1.10E-03 5.38E-05 4.19E-06 3.21E-07 3.80E-05 2.31E-06 
kREP 2.79E-01 1.78E-02 1.50E-03 5.80E-04 1.70E-03 2.43E-04 
kPEE 3.80E-02 2.20E-03 8.50E-03 1.10E-03 9.40E-03 1.74E-04 
kPC 1.01E-05 2.90E-05 1.49E-04 2.22E-04 6.18E-06 1.78E-05 
kEERE 8.15E-01 1.04E-02 2.70E-03 1.00E-03 4.00E-03 1.32E-04 
kEELE 9.06E-01 7.00E-03 1.97E-02 4.27E-04 1.92E-02 2.42E-04 
kEEC 1.40E-03 2.50E-03 1.81E-04 2.14E-04 7.56E-05 6.35E-05 
kLELY 1.77E-01 3.40E-03 2.39E-02 2.36E-04 2.36E-02 9.56E-05 
kLEC 2.51E-01 2.90E-03 2.26E-04 5.59E-04 8.96E-04 1.69E-04 
kDLY 3.08E-01 1.08E-02 2.50E-03 6.66E-04 4.00E-03 7.64E-05 
kEEP 3.69E-01 6.60E-03 3.74E-04 4.34E-04 5.59E-05 7.07E-05 
kMC 2.19E-05 1.19E-05 4.54E-06 2.43E-07 2.19E-05 1.28E-06 
kMEE 4.18E-07 9.02E-07 5.18E-06 6.19E-07 8.87E-07 1.11E-06 
kREC 9.07E-05 2.87E-04 2.08E-04 2.56E-04 1.03E-05 2.18E-05 
kCLY 2.93E-01 7.30E-03 8.00E-03 4.25E-04 6.90E-03 1.73E-04 
  0.3:1 0.6:1 
Parameters 
(1/min) 
mean s.d. mean s.d. 
kMP 4.83E-05 2.69E-06 2.50E-05 2.73E-06 
kREP 2.38E-04 1.64E-04 3.20E-03 1.97E-05 
kPEE 8.90E-03 2.82E-04 3.60E-03 3.17E-05 
kPC 3.44E-06 9.88E-06 2.85E-05 3.43E-05 
kEERE 2.80E-03 3.94E-04 7.01E-06 1.18E-05 
kEELE 1.68E-02 1.87E-04 1.90E-02 5.64E-05 
kEEC 3.97E-04 1.39E-04 7.39E-05 3.59E-05 
kLELY 2.21E-02 2.01E-04 1.97E-02 9.07E-05 
kLEC 1.14E-04 2.43E-04 6.76E-05 4.04E-05 
kDLY 1.37E-02 1.57E-04 1.49E-02 5.99E-05 
kEEP 2.30E-03 8.30E-05 6.50E-03 4.83E-05 
kMC 3.75E-05 1.81E-06 6.97E-05 4.51E-06 
kMEE 3.31E-06 1.21E-06 9.15E-06 2.19E-06 
kREC 6.68E-05 1.51E-04 1.60E-03 3.48E-05 
kCLY 6.60E-03 1.51E-04 1.10E-02 8.68E-05 
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Table 5.3. Optimized rate parameters based on the simplified model (kPC = kREC = 0) 
PEI 0:1 0.1:1 
Parameters 
(1/min) 
mean s.d. mean s.d. mean s.d. 
kMP 1.10E-03 6.03E-05 3.27E-06 2.64E-07 3.60E-05 2.21E-06 
kREP 2.83E-01 5.50E-03 3.70E-05 5.12E-05 2.10E-03 5.56E-04 
kPEE 3.69E-02 1.80E-03 4.20E-03 9.02E-05 9.20E-03 2.12E-04 
kEERE 8.07E-01 1.05E-02 1.80E-03 1.77E-04 3.70E-03 5.02E-04 
kEELE 9.02E-01 9.60E-03 1.80E-02 1.66E-04 1.78E-02 1.38E-04 
kEEC 1.30E-03 4.04E-04 5.27E-05 7.81E-05 3.81E-05 6.72E-05 
kLELY 1.74E-01 6.10E-03 1.70E-02 2.08E-04 2.47E-02 2.92E-04 
kLEC 2.46E-01 7.60E-03 8.14E-04 3.16E-04 1.54E-04 4.16E-04 
kDLY 3.03E-01 1.26E-02 1.21E-02 3.89E-04 4.80E-03 4.92E-04 
kEEP 3.69E-01 7.30E-03 7.52E-05 7.17E-05 2.27E-04 1.35E-04 
kMC 1.06E-05 1.11E-06 8.45E-06 6.74E-07 2.29E-05 1.76E-06 
kMEE 3.77E-07 9.29E-08 5.52E-06 3.88E-07 1.50E-06 1.25E-06 
kCLY 2.87E-01 8.70E-03 2.06E-02 1.33E-04 7.30E-03 4.40E-04 
  0.3:1 0.6:1 
Parameters 
(1/min) 
mean s.d. mean s.d. 
kMP 3.51E-05 2.47E-06 2.63E-05 2.04E-06 
kREP 7.69E-04 5.53E-04 3.20E-03 2.52E-04 
kPEE 3.70E-03 7.28E-04 4.00E-03 4.35E-04 
kEERE 4.20E-03 4.07E-04 3.56E-04 5.10E-04 
kEELE 6.10E-03 9.40E-04 1.87E-02 6.97E-04 
kEEC 2.88E-04 3.18E-04 1.50E-04 2.99E-04 
kLELY 2.64E-02 6.06E-04 1.95E-02 4.08E-04 
kLEC 1.70E-03 1.50E-03 1.24E-04 2.63E-04 
kDLY 2.61E-02 1.90E-03 1.50E-02 7.09E-04 
kEEP 2.60E-03 9.33E-04 6.00E-03 3.98E-04 
kMC 5.67E-05 3.69E-06 7.06E-05 2.39E-06 
kMEE 1.03E-05 3.55E-06 6.85E-06 2.67E-06 
kCLY 1.38E-02 5.89E-04 1.11E-02 2.52E-04 
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Table 5.4. Residual sum of square values for the initial 16-parameters models and the simplified 
((kPC = kREC = 0) 14-parameters models 
  Vectors 
Number of fitted 
parameters in 
models PEI 0:1 0.1:1 0.3:1 0.6:1 
16 1.43E+11 9.44E+07 1.50E+09 3.82E+09 3.70E+09 
14 1.49E+11 3.82E+07 1.38E+09 1.98E+09 3.72E+09 
 
Table 5.5. Parameters optimized to fit data of PEI-mediated delivery with either  
 kEEC=0 kLEC=0 
Parameters 
(1/min) 
mean s.d. mean s.d. 
kMP 1.00E-03 6.31E-05 1.20E-03 9.18E-05 
kREP 2.89E-01 5.00E-03 2.96E-01 9.00E-04 
kPEE 3.56E-02 2.10E-03 3.35E-02 8.84E-04 
kEERE 8.40E-01 8.40E-03 8.04E-01 7.81E-04 
kEELE 8.67E-01 9.20E-03 9.94E-01 2.40E-03 
kEEC 0.00E+00 0.00E+00 1.40E-01 1.90E-03 
kLELY 1.61E-01 6.92E-04 1.79E-01 3.60E-03 
kLEC 2.31E-01 1.40E-03 0.00E+00 0.00E+00 
kDLY 2.71E-01 4.50E-03 2.89E-01 3.70E-03 
kEEP 3.55E-01 5.20E-03 3.80E-01 6.23E-05 
kMC 1.05E-05 7.62E-07 3.99E-05 4.51E-07 
kMEE 3.83E-07 2.64E-01 1.40E-06 1.91E-06 
kCLY 6.40E-03 2.64E-01 1.50E-01 6.48E-05 
Sum of squares 1.59E+11 1.13E+11 
AICc score 661 652 
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